Home Cart Sign in  
Chemical Structure| 3543-75-7 Chemical Structure| 3543-75-7
Chemical Structure| 3543-75-7

*Storage: Inert atmosphere,2-8°C.

Bendamustine HCl

CAS No.: 3543-75-7

Bendamustine HCl is a DNA-damaging agent with IC50 of 50 μM.

Synonyms: SDX-105;Bendamustine (hydrochloride);Cytostasane HCl;SDX105 HCl;Bendamustine hydrochloride

4.5 *For research use only!

Cat. No.: A168000 Purity: 99%

Change View

Size Price

USA Stock *0-1 Day

Global Stock *5-7 Days

In Stock
1mg łÇÊ¶Ê In Stock In Stock Login
5mg łÇË¶Ê In Stock In Stock Login
10mg łÇÿ¶Ê In Stock In Stock Login
50mg łËÿ¶Ê In Stock In Stock Login
100mg ł§Ê¶Ê In Stock In Stock Login
250mg łÿ§¶Ê In Stock In Stock Login
1g łÇËî¶Ê In Stock In Stock Login
5g łÍÿÇ¶Ê In Stock In Stock Login

Please Login or Create an Account to: See VIP prices and availability

  • 1mg

    łÇʶÊ

  • 5mg

    łÇ˶Ê

  • 10mg

    łÇÿ¶Ê

  • 50mg

    łËÿ¶Ê

  • 100mg

    ł§Ê¶Ê

  • 250mg

    łÿ§¶Ê

  • 1g

    łÇËî¶Ê

  • 5g

    łÍÿǶÊ

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online technical Q&A
Product Citations

Product Details of [ Bendamustine HCl ]

CAS No. :3543-75-7
Formula : C16H22Cl3N3O2
M.W : 394.72
Synonyms :
SDX-105;Bendamustine (hydrochloride);Cytostasane HCl;SDX105 HCl;Bendamustine hydrochloride
MDL No. :MFCD01658758
InChI Key :ZHSKUOZOLHMKEA-UHFFFAOYSA-N
Pubchem ID :77082

Safety of [ Bendamustine HCl ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H317-H319
Precautionary Statements:P280-P305+P351+P338

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description Reference
B cell lymphoma cell lines 0.625-4.994 μM 48 hours NL101 significantly inhibited the proliferation of B cell lymphoma cell lines PMC7847677
Primary B cell lymphoma cells 3.5 μM NL101 induced cell death in primary B cell lymphoma cells PMC7847677
μM1S 1.6–4.8μM 48 hours To evaluate the cytotoxicity of EDO-S101 on μM cell lines, the results showed that EDO-S101 exhibited significant cytotoxicity in all cell lines with IC50 values between 1.6 and 4.8 μM. PMC5477689
μM1R 20μM 48 hours To evaluate the cytotoxicity of Bendamustine on μM cell lines, the results showed that Bendamustine had an IC50 value of 20 μM in the μM1R cell line, significantly higher than EDO-S101. PMC5477689
CLL-B cells 0.1, 30, 90 μM 48 hours Bendamustine in combination with PF-06747143 showed synergistic effects in CLL-B cells, increasing cell death rates. PMC5438492
U87MG 5.5 - 65.3 μM To evaluate the inhibitory effect of Bendamustine on cell proliferation PMC5830080

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description Reference
NOD-SCID mice Lymphoma xenograft model Intravenous injection 62.5 mg Once daily for 5 consecutive days NL101 significantly inhibited the growth of lymphoma xenograft models and prolonged the survival of mice PMC7847677
CB17-SCID mice subcutaneous plasmacytoma model intravenous injection 62.5 mg 5% Imiquimod cream Every second day for 6 consecutive days To evaluate the anti-tumor activity of EDO-S101 in the CB17-SCID mouse subcutaneous plasmacytoma model, the results showed that EDO-S101 significantly inhibited tumor growth and prolonged survival. PMC5477689
Mice JVM-13 CLL xenograft mouse model Intraperitoneal injection Low dose group: 10 mg/kg, high dose group: 30 mg/kg Every other day for 14 days Bendamustine in combination with PF-06747143 showed synergistic effects in the CLL xenograft model, significantly improving survival rates. PMC5438492
CD1-nu/nu mice Subcutaneous injection of U251, U87MG, and T98G cells Intravenous injection 30 mg/kg Days 19 and 20, followed by another 2-day treatment cycle 28 days later To evaluate the antitumor effect of Tinostamustine on tumor growth PMC5830080
NOD.Cg-PrkdcscidIl2rgtm1Wjl/SzJ mice MCL xenograft model Intraperitoneal injection 40 mg/kg Once daily for one week To evaluate the anti-tumor activity of Bendamustine in the MCL xenograft model, results showed that the anti-tumor activity of Bendamustine was comparable in mice transplanted with R clone and CTRL cells PMC4094598
B-NSG mice MV4-11-luc xenograft model Intravenous injection 30 mg/kg Once daily for 7 days To evaluate the anti-leukemia effects of NL101 and BMN673 combination therapy in AML xenograft models PMC6306376

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02793583 Diffuse Large B-Cell Lymphoma ... More >> Follicular Lymphoma Marginal Zone Lymphoma Small Lymphocytic Lymphoma Mantle Cell Lymphoma Less << Phase 2 Phase 3 Recruiting July 2019 -
NCT01096992 Leukemia Phase 1 Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02477215 Multiple Myeloma Phase 1 Phase 2 Active, not recruiting May 1, 2020 United States, Wisconsin ... More >> Froedtert Hospital and the Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT03609593 Chronic Lymphocytic Leukemia Phase 2 Not yet recruiting December 31, 2025 United States, New York ... More >> Columbia University Medical Center Not yet recruiting New York, New York, United States, 10032 Less <<
NCT01317901 B-cell Small Lymphocytic Lymph... More >>oma Recurrent Less << Phase 1 Completed - United States, Alabama ... More >> Site Reference ID/Investigator# 61543 Birmingham, Alabama, United States, 35294 United States, Georgia Site Reference ID/Investigator# 61542 Augusta, Georgia, United States, 30912 United States, Nebraska Site Reference ID/Investigator# 61523 Omaha, Nebraska, United States, 68114 United States, New Jersey Site Reference ID/Investigator# 61522 Hackensack, New Jersey, United States, 07601 United States, North Carolina Site Reference ID/Investigator# 61544 Chapel Hill, North Carolina, United States, 27599-7305 United States, Washington Site Reference ID/Investigator# 61524 Seattle, Washington, United States, 98109-1023 Less <<
NCT01686321 Aggressive Lymphoma Phase 2 Unknown October 2017 Germany ... More >> Prof. Trümper Recruiting Göttingen, Germany, 37075 Contact: Elke Stitz    +49551398546    brenda.studie@med.uni-goettingen.de    Contact: Florian Zettl, MD    +49551398546    brenda.studie@med.uni-goettingen.de    Sub-Investigator: Lorenz Trümper, Prof. Dr.          Principal Investigator: Florian Zettl, MD Less <<
NCT01458366 Non-Hodgkin's Lymphoma Phase 1 Phase 2 Active, not recruiting October 2021 United States, Pennsylvania ... More >> Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT01701076 Multiple Myeloma Phase 2 Completed - Switzerland ... More >> Kantonsspital St. Gallen St. Gallen, Switzerland, 9000 Less <<
NCT02320487 - Active, not recruiting - -
NCT02499627 Lymphatic Diseases Phase 2 Recruiting October 2021 Italy ... More >> A.O S.Orsola-Malpighi Recruiting Bologna, BO, Italy, 40138 Principal Investigator: Vittorio Stefoni, MD          Spedali Civili Recruiting Brescia, BS, Italy, 25123 Principal Investigator: Giuseppe Rossi, MD          Fondazione IRCCS Milano INT Recruiting Milano, MI, Italy, 20133 Principal Investigator: Paolo Corradini, Prof.          AO Niguarda Ca' Granda Not yet recruiting Milano, MI, Italy, 20162 Principal Investigator: Chiara Rusconi, MD          Istituto Clinico Humanitas Not yet recruiting Rozzano, MI, Italy, 20089 Principal Investigator: Armando Santoro, Prof.          AOU Città della Salute e della Scienza Recruiting Torino, TO, Italy, 10126 Principal Investigator: Umberto Vitolo, MD          IRCCS Fondazione Pascale Recruiting Napoli, Italy, 80131 Principal Investigator: Antonello Pinto, MD Less <<
NCT02320487 Chronic Lymphocytic Leukemia Phase 2 Active, not recruiting February 22, 2019 -
NCT01078142 Follicular Lymphoma ... More >> Mantle Cell Lymphoma Less << Phase 1 Phase 2 Completed - Germany ... More >> Universitätsmedizin Mainz Mainz, Rheinland-Pfalz, Germany, 55131 Less <<
NCT01317901 - Completed - -
NCT01491841 Non-Hodgkin's Lymphoma Phase 1 Phase 2 Active, not recruiting November 2021 United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27705 Less <<
NCT03623373 Mantle Cell Lymphoma Phase 1 Recruiting November 30, 2025 United States, Missouri ... More >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Brad S Kahl, M.D.    314-747-6250    bkahl@wustl.edu    Principal Investigator: Brad S Kahl, M.D.          Sub-Investigator: Nancy Bartlett, M.D.          Sub-Investigator: Amanda F Cashen, M.D.          Sub-Investigator: Todd Fehniger, M.D., Ph.D.          Sub-Investigator: Armin Ghobadi, M.D.          Sub-Investigator: Daniel Guy, M.D.          Sub-Investigator: Neha Mehta-Shah, M.D.          Sub-Investigator: Kathryn Trinkaus, Ph.D. Less <<
NCT02747732 Diffuse Large B Cell Lymphoma ... More >> Primary Mediastinal (Thymic) Large B-cell Lymphoma Transformed Indolent Lymphoma Recurrent Disease Refractory Cancer Less << Phase 2 Recruiting October 2021 Israel ... More >> Dr. Meirav Kedmi Not yet recruiting Ramat Gan, Israel, 5262179 Contact: Meirav Kedmi, MD       mailto:Meirav.Kedmi@sheba.health.gov.il    Contact: Aliza Ackerstein, MASTER       Aliza.Ackerstein@sheba.health.gov.il    Sheba medical organization Recruiting Ramat Gan, Israel Contact: Meirav Kedmi, MD    972-3-530-2127    Meirav.kedmi@sheba.health.gov.il    Contact: Aliza Ackerstein, Msc    972-3-5308402    aliza.ackerstein@sheba.health.gov.il Less <<
NCT01369849 Chronic Lymphocytic Leukemia ... More >> Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Less << Phase 1 Phase 2 Completed - -
NCT01369849 - Completed - -
NCT01029730 Lymphoma Phase 2 Completed - -
NCT02320383 Chronic Lymphocytic Leucemia Phase 2 Active, not recruiting September 2022 Germany ... More >> German CLL Study Group Cologne, Germany, 50923 Less <<
NCT01029730 - Completed - -
NCT00790855 - Terminated(Lack of Response) - -
NCT00790855 Acute Myeloid Leukemia ... More >> Myelodysplastic Syndrome Acute Lymphoblastic Leukemia Chronic Myeloid Leukemia Less << Phase 1 Phase 2 Terminated(Lack of Response) - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01168804 Multiple Myeloma Phase 2 Completed - Austria ... More >> Medical University Hospital Graz Graz, Austria, 8036 Hospital Elisabethinen Linz Linz, Austria, 4010 LKH Salzburg, 3rd Med. Dept. Salzburg, Austria, 5020 Med. University Vienna, Clinic for Internal Medicine 1 (Hematology and Hemostaseology) Vienna, Austria, 1090 Hanusch Hospital Vienna Vienna, Austria, 1140 Wilhelminenspital Vienna Vienna, Austria, 1160 Clinic Wels-Grieskirchen, 4th Internal Dept. Wels, Austria, 4600 Czech Republic Faculty Hospital Brno Brno, Czech Republic, 63900 Less <<
NCT01871675 Lymphoma Chro... More >>nic Lymphocytic Leukemia Non-Hodgkin Lymphoma T-cell Lymphoma Less << Phase 1 Completed - United States, Colorado ... More >> The Colorado Blood Cancer Institute Denver, Colorado, United States, 80218 United States, Florida Florida Cancer Specialists Sarasota, Florida, United States, 34232 United States, Oklahoma Oklahoma University Oklahoma City, Oklahoma, United States, 73104 United States, Tennessee Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37203 Less <<
NCT00992134 Lymphoma, Mantle-Cell Phase 2 Completed - Italy ... More >> Department of Hematology, Ospedale San Bortolo Vicenza, VI, Italy, 36100 Less <<
NCT00389051 Non-Hodgkin's Lymphoma Phase 1 Completed - Japan ... More >> Kanagawa, Japan Kyoto, Japan Nagoya, Japan Tokyo, Japan Less <<
NCT03424122 B-cell Lymphoma Phase 1 Recruiting December 13, 2020 United States, Nevada ... More >> Comprehensive Cancer Centers of Nevada Recruiting Las Vegas, Nevada, United States, 89169 Contact: Study Coordinator    702-952-3400       United States, Texas Texas Oncology-Austin Midtown Recruiting Austin, Texas, United States, 78705 Contact: Study Coordinator    512-421-4100       Texas Oncology-Baylor Charles A. Sammons Cancer Center Recruiting Dallas, Texas, United States, 75246 Contact: Study Coordinator    214-370-1000       Texas Oncology-San Antonio Northeast Recruiting San Antonio, Texas, United States, 78217 Contact: Study Coordinator    210-656-7177       Texas Oncology San Antonio Medical Center Recruiting San Antonio, Texas, United States, 78240 Contact: Study Coordinator    210-595-5300 Less <<
NCT01754402 Multiple Myeloma Phase 1 Phase 2 Active, not recruiting January 1, 2023 United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT02623920 Diffuse Large B Cell Lymphoma ... More >> Mediastinal Large B-cell Lymphoma Grey Zone Lymphoma High Grade B Cell Lymphoma Follicular Lymphoma Marginal Zone Lymphoma Small Lymphocytic Lymphoma Less << Phase 2 Withdrawn(Pharmaceutical compa... More >>ny supplying the drug withdraw financial support. PI has decided to close study prior to enrollment of any patients.) Less << - United States, Arizona ... More >> Arizona Cancer Center at UMC North Tucson, Arizona, United States, 85724 Less <<
NCT01238146 Extranodal Marginal Zone B-cel... More >>l Lymphoma of Mucosa-associated Lymphoid Tissue Nodal Marginal Zone B-cell Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Splenic Marginal Zone Lymphoma Less << Phase 1 Phase 2 Withdrawn(No patients accrued.... More >>) Less << - United States, Ohio ... More >> Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less <<
NCT00758693 Chronic Lymphocytic Leukemia Phase 2 Withdrawn(Funding was withdraw... More >>n due to insufficient accrual) Less << - United States, Kentucky ... More >> University of Kentucky Lexington, Kentucky, United States, 40536 Less <<
NCT02996773 Acute Lymphoblastic Leukemia ... More >> Acute Myelogenous Leukemia Myelodysplastic Syndromes Chronic Myelogenous Leukemia Juvenile Myelomonocytic Leukemia Lymphoma,Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Follicular Marginal Zone Lymphoma Large Cell Lymphoma Mantle-Cell Lymphoma Gray Zone Lymphoma Burkitt Lymphoma Less << Phase 1 Phase 2 Recruiting April 2022 United States, Arizona ... More >> The University of Arizona Cancer Center Recruiting Tucson, Arizona, United States, 85724 Contact: Olga Ambriz    (520) 694-4767    oambriz@email.arizona.edu    Principal Investigator: Emmanuel Katsanis, MD          Sub-Investigator: Faiz Anwer, MD          Sub-Investigator: Daniel Persky, MD          Sub-Investigator: Soham Puvvada, MD          Sub-Investigator: Ali McBride, PharmD, MS, BCPS          Sub-Investigator: Denise J. Roe, DrPH          Sub-Investigator: Murali Kodali, MD          Sub-Investigator: Lisa Kopp, DO          Sub-Investigator: Ravitharan Krishnadasan, MD          Sub-Investigator: Sandra Kurtin, NPC          Sub-Investigator: Laura McPheeters, NP          Sub-Investigator: Jana Montez, NP          Sub-Investigator: Lauren Nichols, MD          Sub-Investigator: Luz Pelayo-Katsanis, RN, PNP          Sub-Investigator: Lauren Sapp, NP          Sub-Investigator: Katherine Whitney, NP          Sub-Investigator: Andrew Yeager, MD          Sub-Investigator: Yi Zeng, MD Less <<
NCT01313611 Follicular Lymphoma Phase 2 Terminated(Treament with ritux... More >>imab during maintenance phase was stoped, according to DSMC recommendations, since 3 cases of deaths occured.) Less << - -
NCT02072967 - Completed - Russian Federation ... More >> City Clinical Hospital #8 Barnaul, Russian Federation Chelyabinsk Regional Oncology Dispensary/15 Chelyabinsk, Russian Federation, 454087 Vologda Regional Clinical Hospital #2 Cherepovets, Russian Federation Regional Oncology Dispensary/35 Irkutsk, Russian Federation, 664035 Irkutsk Regional Сlinical Hospital/31 Irkutsk, Russian Federation, 664079 Kaluga Regional Clinical Hospital/02 Kaluga, Russian Federation, 248007 District Cancer center od Khanty -Mansiysk Khanty-Mansiysk, Russian Federation City Сlinical Hospital#7/25 Krasnoyarsk, Russian Federation, 660003 Regional Сlinical Hospital/12 Krasnoyarsk, Russian Federation, 660022 Adygei Regional Clinical Oncology Dispensary/11 Maykop, Russian Federation, 385017 Scientific Medical Surgical Center n.a.I.V.Pyrogov/17 Moscow, Russian Federation, 105203 European Medical Center Moscow, Russian Federation, 105229 RONC n.a.N.N.Blokhin/18 Moscow, Russian Federation, 115478 Сentral Clinical Hospital n.a. Semashko N.A./30 Moscow, Russian Federation, 129128 Moscow Scientific Research Oncology Institution n.a.P.A. Gertzen/37 Moscow, Russian Federation, 443099 Central Clinical Hospital of Department of Presidential Affairs Moscow, Russian Federation Municipal Сlinical Hospital № 12/20 Nizhniy Novgorod, Russian Federation, 603003 Novosibirsk State Regional Clinical Hospital/23 Novosibirsk, Russian Federation, 630087 Medical Radiology Scientific Center/38 Obninsk, Russian Federation, 249036 Omsk Regional Clinical Hospital/40 Omsk, Russian Federation, 644111 City Сlinical Hospital#1 n.a.Kabanov A.N./13 Omsk, Russian Federation, 644112 Orenburg State Medical Academy/05 Orenburg, Russian Federation, 460000 Rostov Scientific Research Oncology Institution/01 Rostov-on-Don, Russian Federation, 344037 City Сlinical Oncological Dispensary/22 Saint-Petersburg, Russian Federation, 197022 City Сlinical Hospital#31/08 Saint-Petersburg, Russian Federation, 197110 Military-Medical Academy n.a. Kirova Saint-Petersburg, Russian Federation, 197758 Scientific Research Oncological Institution n.a. Petrov N.N./29 Saint-Petersburg, Russian Federation, 197758 Samara State Medical University' Clinics/36 Samara, Russian Federation, 443099 Road Clinical Hospital on Rostov-Main Station OAO RZhD/06 Smolensk, Russian Federation, 214025 Surgut Regional Clinical Hospital Surgut, Russian Federation Tula Regional Clinical Hospital/21 Tula, Russian Federation, 300053 Volgograd Regional Clinical Oncology Dispensary#1/10 Volgograd, Russian Federation, 400138 Vologda Regional Clinical Hospital/39 Vologda, Russian Federation, 160002 Yekaterinburg Regional Clinical Hospital #1 Yekaterinburg, Russian Federation Sakhalin Regional Oncology Dispensary/32 Yuzhno-Sakhalinsk, Russian Federation, 693010 Less <<
NCT01165112 Recurrent Adult Diffuse Large ... More >>Cell Lymphoma Recurrent Adult Hodgkin Lymphoma Less << Phase 1 Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT01165112 - Completed - -
NCT03311126 Mantle Cell Lymphoma ... More >> Non-hodgkin Lymphoma Non Hodgkin Lymphoma Less << Phase 2 Recruiting May 15, 2026 United States, Wisconsin ... More >> University of Wisconsin Carbone Cancer Center Recruiting Madison, Wisconsin, United States, 53792 Contact: Cancer Connect    800-622-8922    cancerconnect@uwcarbone.wisc.edu    Principal Investigator: Julie Chang, MD Less <<
NCT01754402 - Active, not recruiting - -
NCT01222260 AL Amyloidosis Phase 2 Active, not recruiting December 2021 United States, Massachusetts ... More >> Tufts Medical Center Boston, Massachusetts, United States, 02111 Boston Medical Center Boston, Massachusetts, United States, 02118 United States, Michigan Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, New York Mt. Sinai Medical Center New York, New York, United States, 10023 Columbia University New York, New York, United States, 10032 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT01929265 Indolent Non-follicular ... More >> Non-Hodgkin's Lymphoma Less << Phase 2 Completed - Italy ... More >> SC Ematologia - AO SS. Antonio e Biagio e C. Arrigo Alessandria, AL, Italy, 15121 SC Ematologia Spedali Civili Brescia, BS, Italy Divisione di Ematologia e Trapianti, Ospedale San Maurizio Bolzano, BZ, Italy Divisione di Ematologia, Centro Trapianto di Cellule Staminali San Giovanni Rotondo, Foggia, Italy Divisione Ematologia I , Ospedale San Martino Genova, GE, Italy S.C. Ematologia Azienda Ospedaliera Papardo Messina, ME, Italy Divisione di Oncologia Medica ed Ematologia, Istituto Clinico Humanitas Rozzano, Milano, Italy Divisione di Ematologia Ospedale Niguarda Milano, MI, Italy Centro Oncologico Modenese Modena, MO, Italy Ematologia Azienda Ospedaliero Universitaria Paolo Giaccone Palermo, PA, Italy Div. Oncologia Medica - CRO, Centro di Riferimento Oncologico Aviano, PN, Italy UOC Ematologia 1/CTMO, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico Milano, Italy Oncoematologia Istituto Pascale Napoli, Italy S.C.D.U Ematologia Azienda Ospedaliero Universitaria Maggiore Novara, Italy UO Ematologia Università - Policlinico San Matteo Pavia, Italy Ematologia Ospedale Santo Spirito Pescara, Italy UOA Ematologia, Ospedale Civile Ospedale G. da Saliceto Piacenza, Italy Div. Ematologia AO Bianchi Melacrino Morelli Reggio Calabria, Italy Ematologia, Azienda Ospedaliera Arcispedale "S.Maria Nuova" Reggio Emilia, Italy Ematologia, Università "La Sapienza" Roma, Italy Clinica Ematologia Policlino Le Scotte Siena, Italy Struttura Complessa di Onco-Ematologia Azienda Ospedaliera S.Maria Terni, Italy SC Ematologia - Città della Salute e della Scienza Torino, Italy SC Ematologia U - Città della Salute e della Scienza Torino, Italy Clinica Ematologica e Unità di Terapie Cellulari 'Carlo Melzi' AOU S. Maria della Misericordia Udine, Italy Less <<
NCT00139841 Non-Hodgkin's Lymphoma PHASE3 COMPLETED 2025-10-09 University of Alabama Birmingh... More >>am, Birmingham, Alabama, 35233, United States|Arizona Cancer Center, Tucson, Arizona, 85724, United States|Alta Bates Comprehensive Cancer Center, Berkeley, California, 94704, United States|Tower Hematology and Oncology Medical Group, Beverly Hills, California, 90211, United States|Moores UCSD Cancer Center, La Jolla, California, 92093, United States|USC/Norris Cancer Hospital, Los Angeles, California, 90033, United States|Comprehensive Cancer Center - Desert Regional Medical Center, Palm Springs, California, 92662, United States|Stanford University Division of Oncology, Stanford, California, 94305, United States|University of Colorado Cancer Center, Aurora, Colorado, 80010, United States|Yale University School of Medicine, New Haven, Connecticut, 06520, United States|Georgetown University Medical Center, Washington, District of Columbia, 20007, United States|Rush University Medical Center, Chicago, Illinois, 60612, United States|Indiana Oncology Hematology Consultants, A Division of AHN, Indianapolis, Indiana, 46202, United States|Markey Cancer Center, University of Kentucky Medical Center, Lexington, Kentucky, 40536, United States|LSU Health Sciences Center, Feist Weiller Cancer Center, Shreveport, Louisiana, 71130, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02115, United States|University of Michigan Cancer Center, Ann Arbor, Michigan, 48109, United States|Henry Ford Health System, Detroit, Michigan, 48202, United States|Washington University School of Medicine in St. Louis, St. Louis, Missouri, 63110, United States|Nevada Cancer Institute, Las Vegas, Nevada, 89135, United States|University of New Mexico Cancer Research and Treatment Center, Albuquerque, New Mexico, 87131, United States|Roswell Park Cancer Institute, Buffalo, New York, 14263, United States|Weill Cornell Cancer Care Center, New York, New York, 10021, United States|Interlakes Foundation, Inc., Rochester, New York, 14623, United States|University of Rochester Medical Center, James P. Wilmot Cancer Center, Rochester, New York, 14642, United States|Duke University School of Medicine, Durham, North Carolina, 27710, United States|The Cleveland Clinic Foundation Taussig Cancer Center, Cleveland, Ohio, 44195, United States|The West Clinic/ACORN, Memphis, Tennessee, 38138, United States|Sarah Cannon Research Institute, Nashville, Tennessee, 37203, United States|Arlington Cancer Center, Arlington, Texas, 76012, United States|University of Virginia Cancer Center, Charlottesville, Virginia, 22908, United States|University of Wisconsin, Madison, Wisconsin, 53792, United States|Cross Cancer Institute, Edmonton, Alberta, T6G 1Z2, Canada|British Columbia Cancer Agency, Vancouver, British Columbia, V5Z 4E6, Canada|Queen Elizabeth Health Sciences Centre, Halifax, Nova Scotia, B3H 1V7, Canada|Ottawa Hospital - General Campus, Ottawa, Ontario, KIH8L6, Canada|Hopital Notre-Dame du CHUM, Montreal, Quebec, H2: 4M1, Canada|Hopital du Sacre Couer de Montreal, Montreal, Quebec, H4J 1C5, Canada|Saskatchewan Cancer Center Agency, Saskatoon, Saskatchewan, S7N 4H4, Canada|Hospital Espanol Auxilio Mutuo, Auxilio Mutuo Cancer Center, San Juan, 00919, Puerto Rico Less <<
NCT01570049 Non-Hodgkin Lymphoma by Clinic... More >>al Course Less << Phase 3 Unknown December 2012 China, Tianjin ... More >> Tianjin Medical University Cancer Institute and Hospital Recruiting Tianjin, Tianjin, China, 300060 Contact: Huaqing Wang, Master    +86-022-2334-0123       Tianjin Medical University Cancer Institute and Hospital Recruiting Tianjin, Tianjin, China, 300060 Contact: Huaqing Wang, Master          Contact: Jian J Yu, Master    +8615336402751    yujj@lanjin.cn Less <<
NCT01990144 Diffuse Large B-cell Lymphoma Phase 2 Unknown February 2016 -
NCT00920855 Multiple Myeloma Phase 1 Phase 2 Completed - United States, California ... More >> Pacific Oncololgy & Hematology Encinitas, California, United States Capitol Hematology Oncology Roseville, California, United States University Of California, San Diego San Diego, California, United States James R. Berenson, M.D., Inc. West Hollywood, California, United States United States, District of Columbia George Washington University Washington, District of Columbia, United States United States, Illinois Northshore University Health System Evanston, Illinois, United States United States, Maryland Alivin & Lois Lapidus Cancer Institute Baltimore, Maryland, United States Center for Cancer and Blood Disorders Bethesda, Maryland, United States United States, Massachusetts Sophia Gordon Cancer Center at Lahey Clinic Burlington, Massachusetts, United States United States, Pennsylvania Geisinger Medical Center Danville, Pennsylvania, United States United States, South Carolina Charleston Hematology Oncology, PA Charleston, South Carolina, United States United States, Tennessee Family Cancer Center, PLLC Collierville, Tennessee, United States United States, Virginia Fairfax Northern Virginia Hematology Oncology Fairfax, Virginia, United States Less <<
NCT00951457 Leukemia, Lymphocytic, Chronic... More >>, B-Cell Less << Phase 1 Phase 2 Completed - Austria ... More >> Medizinische Universitaet Innsbruck, Abtlg. f. Haematologie und Onkologie Innsbruck, Tirol, Austria, A-6020 Landeskrankenhaus Feldkirch Feldkirch, Austria, A-6806 A.ö. Landeskrankenhaus Leoben Leoben, Austria, A-8700 Krankenhaus der Elisabethinen Linz Linz, Austria, A-4010 Krankenhaus der Stadt Linz Linz, Austria, A-4020 Universitaetsklinik f. Innere Medizin III Salzburg, Austria, A-5020 Klinikum Wels-Grieskirchen GmbH Wels, Austria, A-4600 Less <<
NCT00834678 Breast Cancer Phase 1 Phase 2 Completed - United States, Ohio ... More >> Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less <<
NCT00834678 - Completed - -
NCT00984542 Lung Cancer Phase 2 Completed - United States, Kentucky ... More >> Hardin Memorial Hosptial Elizabethtown, Kentucky, United States, 42701 United States, Tennessee The Jones Clinic - Germantown Germantown, Tennessee, United States, 38138 Jackson-Madison County Hospital Jackson, Tennessee, United States, 38301 Baptist Regional Cancer Center at Baptist Riverside Knoxville, Tennessee, United States, 37901 Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States, 37064 Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 Less <<
NCT01657331 Hodgkin Lymphoma ... More >> Anaplastic Large Cell Lymphoma Less << Phase 1 Phase 2 Active, not recruiting April 2019 United States, New York ... More >> Columbia University Medical Center New York, New York, United States, 10019 Canada, British Columbia British Columbia Cancer Agency Vancouver, British Columbia, Canada, V5z 4E6 Canada, Ontario Princess Margaret Hospital Toronto, Ontario, Canada Less <<
NCT01108341 Non-Hodgkin's Lymphoma (NHL) Phase 2 Completed - -
NCT00920855 - Completed - -
NCT01141725 Adult Acute Myeloid Leukemia W... More >>ith 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) de Novo Myelodysplastic Syndromes Myelodysplastic Syndrome With Isolated Del(5q) Untreated Adult Acute Myeloid Leukemia Less << Phase 1 Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT01141725 - Completed - -
NCT01049945 Refractory Multiple Myeloma Phase 1 Phase 2 Unknown - United States, California ... More >> City of Hope Duarte, California, United States, 91010 United States, Florida Mayo Clinic in Florida Jacksonville, Florida, United States, 55904 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637-1470 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Missouri Washington Universtiy School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT01108341 - Completed - -
NCT02187133 Lymphoma, Non-Hodgkin ... More >> Lymphoma Less << Phase 1 Recruiting June 2019 United States, California ... More >> University of California, Davis Recruiting Davis, California, United States, 95616 Contact: Teri Nguyen       crcnguyen@ucdavis.edu    Principal Investigator: Joseph Tuscan, MD          University of California, San Diego Recruiting San Diego, California, United States, 92093 Contact: Jesika Reiner       jreiner@ucsd.edu    Principal Investigator: Matthew Wieduwilt, MD          University of California, San Francisco Recruiting San Francisco, California, United States, 94143 Contact: Erika Cavallone    877-827-3222    cancertrials@ucsf.edu Less <<
NCT01002703 Multiple Myeloma Phase 1 Phase 2 Unknown October 2014 Germany ... More >> University of Leipzig Recruiting Leipzig, Germany, 04103 Contact: Dietger Niederwieser    +4934197 ext 13050    dietger@medizin.uni-leipzig.de    Sub-Investigator: Wolfram Pönisch Less <<
NCT01049945 - Unknown - -
NCT00984542 - Completed - -
NCT01657955 Chronic Lymphocytic Leukemia ... More >> Leukemia Neoplasms Less << Phase 3 Unknown December 2013 China ... More >> Hematologic hospital of Chinese academy of medical sciences Recruiting Tianjin, China Contact: Lu G Qiu, M.D.          Contact: Jian J Yu, Master    +8615336402752    yujj@lanjin.cn    Principal Investigator: Lu G Qiu, M.D. Less <<
NCT01900509 Hodgkin Lymphoma ... More >> Non-Hodgkin Lymphoma Acute Leukemia Less << Phase 1 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT01234467 Diffuse Large B-Cell Lymphoma ... More >> Lymphoma, Diffuse Large-Cell Diffuse Large-Cell Lymphoma Lymphoma Less << Phase 2 Completed - United States, North Carolina ... More >> Seby B. Jones Cancer Center Boone, North Carolina, United States, 28607 University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States, 27599 Northeast Medical Center Concord, North Carolina, United States, 28025 Moses Cone Regional Cancer Center Greensboro, North Carolina, United States, 27403 Leo Jenkins Cancer Center, East Carolina University Medical Center Greenville, North Carolina, United States, 27834 Rex Healthcare Raleigh, North Carolina, United States, 27607 Marion L. Shepard Cancer Center Washington, North Carolina, United States, 27889 Less <<
NCT00076349 Non-Hodgkin's Lymphoma Phase 2 Completed - -
NCT01234467 - Completed - -
NCT02110394 - Completed - Russian Federation ... More >> Republic Clinical Hospital n.a. N.A. Semashko Buryatia, Ulan-Ude, Russian Federation Alexandro-Mariinskaia Regional Clinical Hospital/13 Astrakhan', Russian Federation, 414056 Vologda Reginal Clinical Hospital #2 Cherepovets, Russian Federation Irkutsk Regional Clinical Hospital/08 Irkutsk, Russian Federation, 664079 Kaliningrad City Clinical Hospital Kaliningrad, Russian Federation Regional Clinical Hospital#1/04 Khabarovsk, Russian Federation, 630009 District Cancer Center od Khanty -Mansiysk Khanty-Mansiysk, Russian Federation National Medical Surgical Center n.a.N.I.Pirogov/15 Moscow, Russian Federation, 105203 RONC n.a.N.N.Blokhin/21 Moscow, Russian Federation, 115478 Сentral Clinical Hospital n.a.N.A.Semashko/20 Moscow, Russian Federation, 129128 Central Clinical Hospital of Department of Presidential Affairs Moscow, Russian Federation Haematology Centre at Main Military Clinical Hospital n.a. N.N. Burdenko Moscow, Russian Federation Murmansk Regional Clinical Hospital n.a.P.A.Bayandin/31 Murmansk, Russian Federation, 183047 Nizhniy Novgorod Regional Clinical Hospital n.a.N.A.Semashko/14 Nizhniy Novgorod, Russian Federation, 603126 Medical Radiology Scientific Center/23 Obninsk, Russian Federation, 249036 Omsk Regional Clinical Hospital Omsk, Russian Federation Orenburg State Medical Academy/011 Orenburg, Russian Federation, 460000 Perm regional hospital Perm, Russian Federation Karelia Republican Сlinical Hospital n.a.V.A.Baranov/32 Petrozavodsk, Russian Federation, 185019 Pskov Regional Clinical Hospital Pskov, Russian Federation Rostov Scientific Research Oncology Institution/03 Rostov-on-Don, Russian Federation, 344037 Site 70001 Private Practice Saint-Petersburg, Russian Federation, 197341 Military-Medical Academy n.a. Kirova Saint-Petersburg, Russian Federation, 197758 Samara State Medical University' Clinics/28 Samara, Russian Federation, 443099 Saratov State Medical University n.a. V.I.Razumovskiy Saratov, Russian Federation Road Clinical Hospital on Smolensk station OAO RZhD/12 Smolensk, Russian Federation, 214025 Komi Republican Oncology Dispensary /01 Syktyvkar, Russian Federation, 167904 Tula Regional Clinical Hospital/07 Tula, Russian Federation, 300053 Tyumen Regional Clinical Hospital#1/27 Tyumen, Russian Federation, 625023 Regional Clinical Hospital/26 Ul'yanovsk, Russian Federation, 432063 Volgograd Regional Clinical Oncology Dispensary#1/25 Volgograd, Russian Federation, 400138 Vologda Regional Clinical Hospital Vologda, Russian Federation Yekaterinburg City Hospital #7 Yekaterinburg, Russian Federation Yekaterinburg Regional Clinical Hospital #1 Yekaterinburg, Russian Federation Less <<
NCT01073163 - Completed - -
NCT00426855 - Completed - -
NCT03336333 Chronic Lymphocytic Leukemia ... More >> Small Lymphocytic Lymphoma Less << Phase 3 Recruiting October 2022 -
NCT02753062 Diffuse Large B Cell Lymphoma Phase 2 Recruiting August 2023 Korea, Republic of ... More >> Asan Medical Center Recruiting Seoul, Songpa-gu, Korea, Republic of, 05505 Contact: Dok Hyun Yoon, M.D.,Ph D    82-10-3235-3090    dhyoon@amc.seoul.kr    Contact: Cheolwon Suh, M.D.,Ph D    82-10-3735-3209    csuh@amc.seoul.kr Less <<
NCT00831597 Diffuse Large B-Cell Lymphoma Phase 2 Completed - -
NCT01429025 Refractory/Relapsed Indolent N... More >>on-Hodgkin Lymphoma Less << Phase 1 Active, not recruiting - United States, Iowa ... More >> Medical Oncology and Hematology Associates-West Des Moines Clive, Iowa, United States, 50325 Mercy Cancer Center-West Lakes Clive, Iowa, United States, 50325 Iowa Methodist Medical Center Des Moines, Iowa, United States, 50309 Iowa Oncology Research Association CCOP Des Moines, Iowa, United States, 50309 Medical Oncology and Hematology Associates-Des Moines Des Moines, Iowa, United States, 50309 Medical Oncology and Hematology Associates Des Moines, Iowa, United States, 50314 Mercy Medical Center - Des Moines Des Moines, Iowa, United States, 50314 Iowa Lutheran Hospital Des Moines, Iowa, United States, 50316 Siouxland Hematology-Oncology Sioux City, Iowa, United States, 51101-1733 Mercy Medical Center-Sioux City Sioux City, Iowa, United States, 51104 St. Luke's Regional Medical Center Sioux City, Iowa, United States, 51104 Methodist West Hospital West Des Moines, Iowa, United States, 50266-7700 Mercy Medical Center-West Lakes West Des Moines, Iowa, United States, 50266 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, North Dakota Mid Dakota Clinic Bismarck, North Dakota, United States, 58501 Saint Alexius Medical Center Bismarck, North Dakota, United States, 58501 Sanford Bismarck Medical Center Bismarck, North Dakota, United States, 58501 Less <<
NCT03492775 Indolent Non-hodgkin Lymphoma Phase 3 Recruiting January 5, 2027 Germany ... More >> Klinikum der Universität München Recruiting München, Bavaria, Germany, 81377 Less <<
NCT01125787 Chronic Lymphocytic Leukemia (... More >>CLL) Less << Phase 2 Terminated(Low enrollment) - United States, Florida ... More >> University of Florida Gainesville, Florida, United States, 32610 United States, Nevada Nevada Cancer Institute Las Vegas, Nevada, United States, 89135 Less <<
NCT01073163 Non-Hodgkin's Lymphoma ... More >> Mantle Cell Lymphoma Less << Phase 3 Completed - -
NCT02002598 Multiple Myeloma Phase 1 Phase 2 Recruiting November 2018 United States, New York ... More >> Columbia University Medical Center Recruiting New York, New York, United States, 10032 Contact: Siyang Leng, MD    212-317-4805    sl4076@cumc.columbia.edu    Principal Investigator: Siyang Leng, MD Less <<
NCT01077518 Lymphoma, Follicular Phase 3 Active, not recruiting June 1, 2024 -
NCT00837928 Metastatic Cancer ... More >> Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, Ohio ... More >> Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less <<
NCT01131247 Chronic Lymphocytic Leukemia (... More >>CLL) Less << Phase 2 Withdrawn(PI left institution) - United States, Arizona ... More >> Mayo Clinic PHoenix/Scottsdale, Arizona, United States, 85259 Less <<
NCT01520922 Chronic Lymphocytic Leukemia (... More >>CLL) Leukaemia, Lymphocytic, Chronic Less << Phase 2 Completed - -
NCT01296256 Bendamustine ... More >>Conditioning Therapy Autologous Stem Cell Transplant Aggressive Non Hodgkin's Lymphoma Less << Phase 2 Completed - Spain ... More >> Complejo Hospitalario Universitario de Santiago Santiago, A Coruña, Spain, 15706 Hospital Central de Asturias Oviedo, Asturias, Spain, 33006 Hospital de Jerez Jerez de la Frontera, Cádiz, Spain, 11407 Hospital Son Llátzer Palma de Mallorca, Mallorca, Spain, 07198 Hospital Universitario Virgen de Arrixaca El Palmar, Murcia, Spain, 30120 Clinica Universitaria de Navarra Pamplona, Navarra, Spain Hospital Universitario de Canarias Santa Cruz de Tenerife, Tenerife, Spain Hospital Vall d´Hebron Barcelona, Spain, 08035 Hospital Clinic i Provincial Barcelona, Spain, 08036 H. de la Santa Creu i Sant Pau Barcelona, Spain H.U. 12 de Octubre, Madrid, Spain H.U. Gregorio Marañón, Madrid, Spain H.U. La Paz Madrid, Spain H.U. La Princesa Madrid, Spain Hospital Ramon y Cajal Madrid, Spain H. Clínico Universitario de Salamanca Salamanca, Spain H. U. Marqués de Valdecilla. Santander, Spain Hospital Clinico de Valencia Valencia, Spain, 46010 Hospital Arnau de Vilanova Valencia, Spain, 46015 H. La Fe Valencia, Spain Hospital Clínico Lozano Blesa Zaragoza, Spain, 50009 Less <<
NCT02237261 Multiple Myeloma Phase 2 Active, not recruiting October 2018 Germany ... More >> Mannheimer Onkologie Praxis Mannheim, Ba-Wü, Germany, 68161 Hämatologisch-Onkologische gemeinschaftspraxis Augsburg, Bayern, Germany, 86150 Gemeinschaftspraxis Dr. R. Schlag/Dr. B. Schöttker Würzburg, Bayern, Germany, 97080 Onkologische Schwerpunktpraxis Heidelberg, BW, Germany, 69115 Medizinische Klinik V, Universitätsklinikum Heidelberg, Sektion Multiples Myelom Heidelberg, BW, Germany, 69120 Onkologische Schwerpunktpraxis Dr. G. Kojouharoff Darmstadt, Hessen, Germany, 64295 Hämatologisch-Onkologische Gemeinschaftspraxis am Bethanienkrankenhaus Frankfurt, Hessen, Germany, 60389 Agaplesion Markus Krankenhaus gGmbH, Medizinisches Versorgungszentrum Frankfurt, Hessen, Germany, 60431 Onkologisches Ambulanzzentrum Hannover am Diakoniekrankenhaus Henriettenstift gGmbH Hannover, NRW, Germany, 30171 Onkologische Gemeinschaftspraxis Köln, NRW, Germany, 50677 Klinikum Idar-Oberstein GmbH, Innere Medizin I Idar-Oberstein, Rh-Pfalz, Germany, 55743 Onkologische Schwerpunktpraxis Speyer Speyer, RP, Germany, 67346 Städtische Klinikum Dessau Dessau, Sachsen-Anhalt, Germany, 06847 Klinikum Aschaffenburg, Med. Klinik II Aschaffenburg, Germany, 63739 Onkologische Praxis Oldenburg/Delmenhorst Oldenburg, Germany, 26121 Less <<
NCT01520922 - Completed - -
NCT01010568 - Terminated(Unable to accrue pa... More >>tients due to change in standard CLL therapy) Less << - -
NCT01326702 Adult B Acute Lymphoblastic Le... More >>ukemia Adult Nasal Type Extranodal NK/T-Cell Lymphoma Adult Solid Neoplasm Anaplastic Large Cell Lymphoma Angioimmunoblastic T-Cell Lymphoma Chronic Lymphocytic Leukemia Cutaneous B-Cell Non-Hodgkin Lymphoma Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Hepatosplenic T-Cell Lymphoma Intraocular Lymphoma Lymphomatous Involvement of Non-Cutaneous Extranodal Site Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma Nodal Marginal Zone Lymphoma Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult T-Cell Leukemia/Lymphoma Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides and Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Hairy Cell Leukemia Refractory Plasma Cell Myeloma Small Intestinal Lymphoma Splenic Marginal Zone Lymphoma Testicular Lymphoma Waldenstrom Macroglobulinemia Less << Phase 1 Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT01352312 Chronic Lymphocytic Leukemia ... More >> B-Cell Non-Hodgkin's Lymphoma Less << Phase 1 Terminated(Insufficient accrua... More >>l over 12 mo period) Less << - United States, Pennsylvania ... More >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT00426855 Lymphoma, Non-Hodgkin Phase 1 Phase 2 Completed - -
NCT00661739 Metastatic Breast Cancer Phase 1 Completed - -
NCT02433795 Marginal Zone B-cell Lymphoma Phase 2 Active, not recruiting December 2018 Korea, Republic of ... More >> Chonbuk National University Hospital Jeonju, Jeollabuk-do, Korea, Republic of, 54907 Hallym University Medical Center Anyang-si, Korea, Republic of Chungnam National University Daejeon, Korea, Republic of Gachon University Gil Medical Center Incheon, Korea, Republic of Gyeongsang National University Hospital Jinju, Korea, Republic of Seoul National University Bundang Hospital Seongnam, Korea, Republic of Inje Universit Seoul, Korea, Republic of Korea Cancer Center Hospital Seoul, Korea, Republic of Seoul National University Boramae Hospital Seoul, Korea, Republic of Seoul National University Hospital Seoul, Korea, Republic of The Catholic University of Korea Seoul, Korea, Republic of Less <<
NCT01022021 Lymphoma Early Phase 1 Completed - United States, Kansas ... More >> University of Kansas Medical Center Kansas City, Kansas, United States, 66205 Less <<
NCT01010568 Chronic Lymphocytic Leukemia ... More >> Small Lymphocytic Lymphoma Less << Phase 2 Terminated(Unable to accrue pa... More >>tients due to change in standard CLL therapy) Less << - United States, District of Col... More >>umbia Georgetown University Washington, District of Columbia, United States, 20007 Less <<
NCT00705250 Hodgkin's Disease ... More >> Lymphoma Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00705250 - Completed - -
NCT01315873 Multiple Myeloma Phase 2 Terminated(PI left the institu... More >>tion before all data analysis was completed) Less << - United States, New York ... More >> New York University Langone Medical Center New York, New York, United States, 10016 Less <<
NCT01649622 Leukemia Lymp... More >>homa Less << Phase 2 Withdrawn - -
NCT01500083 Indolent Non-Hodgkin's Lymphom... More >>a Chronic Lymphocytic Leukemia Less << Phase 3 Completed - Canada, Alberta ... More >> CA015 Calgary, Alberta, Canada, T2N 4N2 CA014 Edmonton, Alberta, Canada, T6G 1Z2 Canada, British Columbia CA016 Kelowna, British Columbia, Canada, V1Y 5L3 CA011 Vancouver, British Columbia, Canada, V5Z 4E6 CA013 Victoria, British Columbia, Canada, V8R 6V5 Canada, Manitoba CA012 Winnipeg, Manitoba, Canada, R3E 0V9 Canada, Nova Scotia CA004 Halifax, Nova Scotia, Canada, B3H 2Y9 Canada, Ontario CA009 Brampton, Ontario, Canada, L6R 3J7 CA003 Hamilton, Ontario, Canada, L8V 5C2 CA002 Ottawa, Ontario, Canada, K1H 8L6 CA006 Toronto, Ontario, Canada, M5G 2M9 CA005 Windsor, Ontario, Canada, N8W 2X3 Canada, Quebec CA001 Montreal, Quebec, Canada, H2W 1S6 CA010 Montreal, Quebec, Canada, H4J 1C5 Canada, Saskatchewan CA007 Saskatoon, Saskatchewan, Canada, S7N 4H4 Canada CA008 Quebec, Canada, G1J 1Z4 Less <<
NCT01152203 Advanced Cancer Phase 1 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01891227 Breast Cancer Phase 2 Completed - Austria ... More >> Hämatologie und Onkologie/Interne E, LKH Feldkirch Feldkirch, Austria, A-6807 Universitätsklinik f. Frauenheilkunde und Geburtshilfe, Klin. Abt. f. Gynäkologie Graz, Austria, 8036 Universitätsklinik f. Innere Medizin, Klin.Abt. f. Onkologie Graz, Austria, 8036 Univ.-Klinik f. Frauenheilkunde; Klinische Abt. f. Gynäkologie u. Geburtshilfe Innsbruck, Austria, A-6020 KH Barmh. Schwestern Linz, Innere Medizin I Hämatologie/Onkologie Linz, Austria, A-4010 Kepler Universitätsklinikum, Med Campus III, Klinik f. Interne 3 - Schwerpunkt Hämatologie u. Onkologie Linz, Austria, A-4021 Universitätsklinik für Innere Medizin III Salzburg, Austria, A-5020 Landeskrankenhaus Steyr, Interne Medizin II Steyr, Austria, A-4400 Less <<
NCT00891839 Mantle Cell Lymphoma Phase 2 Completed - United States, California ... More >> Teva Investigational Site 11 Fountain Valley, California, United States Teva Investigational Site 2 Los Angeles, California, United States United States, Florida Teva Investigational Site 35 Orlando, Florida, United States United States, Indiana Teva Investigational Site 30 Lafayette, Indiana, United States United States, Maryland Teva Investigational Site 20 Bethesda, Maryland, United States United States, New Jersey Teva Investigational Site 4 Hackensack, New Jersey, United States United States, New York Teva Investigational Site 3 Buffalo, New York, United States United States, Pennsylvania Teva Investigational Site 43 Gettysburg, Pennsylvania, United States United States, Texas Teva Investigational Site 33 Bryan, Texas, United States Teva Investigational Site 41 Grapevine, Texas, United States United States, Virginia Teva Investigational Site 23 Lynchburg, Virginia, United States Canada Teva Investigational Site 6 Ottawa, Canada Teva Investigational Site 7 Toronto, Canada Less <<
NCT01315873 - Terminated(PI left the institu... More >>tion before all data analysis was completed) Less << - -
NCT01109264 Chronic Lymphocytic Leukemia Phase 2 Completed - China ... More >> Ruijin Hospital Affiliated to Shanghai JiaoTong University School of Medicine Shanghai, China Less <<
NCT01739491 - Withdrawn(The study is cancell... More >>ed. FDA Circular 2013-004 mandates that PMSs like this are not required) Less << November 2016 -
NCT01500083 - Completed - -
NCT02095834 Recurrent Plasma Cell Myeloma ... More >> Refractory Plasma Cell Myeloma Less << Phase 1 Active, not recruiting April 30, 2021 United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00891839 - Completed - -
NCT02224729 Stage I Multiple Myeloma ... More >> Stage II Multiple Myeloma Stage III Multiple Myeloma Less << Phase 2 Active, not recruiting January 2020 United States, Pennsylvania ... More >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT01626352 Diffuse Large B-Cell Lymphoma Phase 2 Completed - United States, Florida ... More >> Florida Cancer Specialists-South Fort Myers, Florida, United States, 33916 Woodlands Medical Specialists Pensacola, Florida, United States, 32503 Florida Cancer Specialists North Saint Petersburg, Florida, United States, 33705 Space Coast Cancer Center Titusville, Florida, United States, 32796 United States, Indiana Providence Medical Group Terre Haute, Indiana, United States, 47802 RHHP/Hope Cancer Center Terre Haute, Indiana, United States, 47802 United States, Michigan Grand Rapids Oncology Program Grand Rapids, Michigan, United States, 49503 United States, Oklahoma Cancer Centers of Southwest Oklahoma Lawton, Oklahoma, United States, 73505 Oklahoma University Oklahoma City, Oklahoma, United States, 73104 United States, Tennessee Tennessee Oncology-Chattanooga Chattanooga, Tennessee, United States, 37404 Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 Less <<
NCT02224729 - Active, not recruiting - -
NCT00879073 Brain Metastases Phase 1 Terminated(Principal Investiga... More >>tor is leaving Moffitt) Less << - United States, Florida ... More >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 Less <<
NCT01626352 - Completed - -
NCT00823797 Adult Anaplastic Astrocytoma ... More >> Adult Anaplastic Oligodendroglioma Adult Giant Cell Glioblastoma Adult Glioblastoma Adult Gliosarcoma Recurrent Adult Brain Neoplasm Less << Phase 2 Completed - United States, Illinois ... More >> Northwestern University Chicago, Illinois, United States, 60611 United States, Utah Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States, 84112 United States, Washington Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00863850 Malignancy Phase 1 Completed - Netherlands ... More >> Please Call For Information Amsterdam, Netherlands, 1066 CX Less <<
NCT00823797 - Completed - -
NCT00947388 Recurrent Small Lymphocytic Ly... More >>mphoma Refractory Chronic Lymphocytic Leukemia Stage III Chronic Lymphocytic Leukemia Stage III Small Lymphocytic Lymphoma Stage IV Chronic Lymphocytic Leukemia Stage IV Small Lymphocytic Lymphoma Less << Phase 1 Terminated(No more eligible pa... More >>tients) Less << - United States, Ohio ... More >> Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT01088984 Leukemia Phase 1 Phase 2 Completed - -
NCT02240719 Recurrent Adult Diffuse Large ... More >>Cell Lymphoma Recurrent Adult Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Refractory Chronic Lymphocytic Leukemia Multiple Myeloma Less << Phase 1 Active, not recruiting December 2019 United States, California ... More >> University of California Davis Sacramento, California, United States, 95817 Less <<
NCT01484626 - Terminated(Celgene would no lo... More >>nger supply lenalidomide for the study) Less << - -
NCT01484626 Multiple Myeloma Phase 1 Phase 2 Terminated(Celgene would no lo... More >>nger supply lenalidomide for the study) Less << - United States, Illinois ... More >> Loyola University Medical Center Maywood, Illinois, United States, 60153 Less <<
NCT01088984 - Completed - -
NCT00959686 T-cell Lymphoma Phase 2 Completed - France ... More >> Dr Gandhi DAMAJ Amiens, France, 80054 Less <<
NCT03343652 Hodgkin's Lymphoma Phase 1 Phase 2 Recruiting March 27, 2020 Russian Federation ... More >> First Pavlov State Medical University of St. Petersburg Recruiting Saint-Petersburg, Russian Federation, 197089 Contact: Natalya B Mikhailova, PhD    +7-921-909-62-09    bmt.lymphoma@gmail.com    Contact: Elena V Kondakova, PhD    +79650094653    kondakovae@mail.ru    Sub-Investigator: Kirill V Lepik, MD Less <<
NCT02168907 B-cell Adult Acute Lymphoblast... More >>ic Leukemia B-cell Chronic Lymphocytic Leukemia Cutaneous B-cell Non-Hodgkin Lymphoma Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Intraocular Lymphoma Nodal Marginal Zone B-cell Lymphoma Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Hairy Cell Leukemia Small Intestine Lymphoma Splenic Marginal Zone Lymphoma Testicular Lymphoma Waldenstr?m Macroglobulinemia Less << Phase 1 Terminated(Slow Accruals) - United States, North Carolina ... More >> Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States, 27157 Less <<
NCT02168140 Adult Lymphocyte Depletion Hod... More >>gkin Lymphoma Adult Lymphocyte Predominant Hodgkin Lymphoma Adult Mixed Cellularity Hodgkin Lymphoma Adult Nasal Type Extranodal NK/T-cell Lymphoma Adult Nodular Sclerosis Hodgkin Lymphoma Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Hepatosplenic T-cell Lymphoma Noncutaneous Extranodal Lymphoma Peripheral T-cell Lymphoma Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Hodgkin Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome T-cell Adult Acute Lymphoblastic Leukemia T-cell Large Granular Lymphocyte Leukemia Less << Phase 1 Recruiting July 2020 United States, North Carolina ... More >> Comprehensive Cancer Center of Wake Forest University Recruiting Winston-Salem, North Carolina, United States, 27157 Contact: Zanetta S. Lamar    336-716-7448    zlamar@wakehealth.edu    Principal Investigator: Zanetta S. Lamar          United States, Pennsylvania Abramson Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Joseph Vena, RN       mailto:Joseph.Vena@uphs.upenn.edu    Contact: Tanya Latorre       mailto:Tanya.Latorre@uphs.upenn.edu Less <<
NCT02315157 Multiple Myeloma ... More >> Plasma Cell Leukemia Less << Phase 1 Withdrawn(Withdrawn by PI) - United States, Pennsylvania ... More >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT01535924 Adult Lymphocyte Depletion Hod... More >>gkin Lymphoma Adult Lymphocyte Predominant Hodgkin Lymphoma Adult Mixed Cellularity Hodgkin Lymphoma Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma Adult Nodular Sclerosis Hodgkin Lymphoma Recurrent Adult Hodgkin Lymphoma Less << Phase 1 Phase 2 Active, not recruiting December 31, 2018 United States, Georgia ... More >> Emory University Atlanta, Georgia, United States, 30322 United States, Ohio Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less <<
NCT00867503 - Completed - -
NCT00867503 Ovarian Cancer Phase 2 Completed - United States, Arizona ... More >> Arizona Cancer Center Tucson, Arizona, United States, 85724 Less <<
NCT01596621 Non-Hodgkin Lymphoma PHASE3 COMPLETED 2017-04-24 Teva Investigational Site 001,... More >> Beijing, 100021, China|Teva Investigational Site 026, Beijing, 100029, China|Teva Investigational Site 022, Beijing, 100044, China|Teva Investigational Site 004, Beijing, 100071, China|Teva Investigational Site 003, Beijing, 100142, China|Teva Investigational Site 002, Beijing, 100191, China|Teva Investigational Site 023, Beijing, 100600, China|Teva Investigational Site 016, Beijing, 100730, China|Teva Investigational Site 021, Beijing, 110108, China|Teva Investigational Site 015, Changchun, 130000, China|Teva Investigational Site 010, Chengdu, 610041, China|Teva Investigational Site 008, Guangzhou, 510000, China|Teva Investigational Site 007, Guangzhou, 510060, China|Teva Investigational Site 011, Hangzhou, 310003, China|Teva Investigational Site 019, Harbin, 150081, China|Teva Investigational Site 025, Hefei, 230022, China|Teva Investigational Site 024, Lanzhou, 620102, China|Teva Investigational Site 012, Nanjing, 210000, China|Teva Investigational Site 013, Nanjing, 210029, China|Teva Investigational Site 006, Shanghai, 200032, China|Teva Investigational Site 005, Shanghai, 200035, China|Teva Investigational Site 009, Shenyang, 110001, China|Teva Investigational Site 027, Shenyang, 110042, China|Teva Investigational Site 020, Suzhou, 215000, China|Teva Investigational Site 014, Tianjin, 300041, China|Teva Investigational Site 018, Xi'an, 710032, China|Teva Investigational Site 017, Zhengzhou, 450000, China Less <<
NCT00899431 Chronic Lymphocytic Leukemia Phase 2 Active, not recruiting May 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03570892 Non-Hodgkin Lymphoma Phase 3 Not yet recruiting May 26, 2025 -
NCT01587040 Neoplasm Malignant Phase 1 Phase 2 Completed - -
NCT00889798 - Active, not recruiting December 2019 -
NCT02788201 Urothelial Carcinoma ... More >> Bladder Cancer Urinary Bladder Neoplasms Less << Phase 2 Recruiting July 1, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT01178086 - Completed - Germany ... More >> PIOH PD Dr. R. Schnell - Dr. H. Schulz - Dr. M. Hellmann Frechen, Germany, 50226 Less <<
NCT01438177 Multiple Myeloma Phase 2 Terminated(PI left institution... More >>.) Less << - United States, New York ... More >> NYU Cancer Institute New York, New York, United States, 10016 Less <<
NCT01178086 - Completed - -
NCT02877550 Follicular Lymphoma Phase 1 Recruiting December 2021 Switzerland ... More >> Universitaetsspital Basel Recruiting Basel, Switzerland, 4031 Contact: Fatime Krasniqi, MD    +41 61 265 5059    KrasniqiF@uhbs.ch    Principal Investigator: Fatime Krasniqi, MD          Istituto Oncologico della Svizzera Italiana Recruiting Bellinzona, Switzerland, 6500 Contact: Anastasios Stathis, MD    +41 91 811 89 31    anastasios.stathis@eoc.ch    Principal Investigator: Anastasios Stathis, MD          Inselspital, Bern Recruiting Bern, Switzerland, CH-3010 Contact: Urban Novak, MD    +41 31 632 19 92    urban.novak@insel.ch    Principal Investigator: Urban Novak, MD          Kantonsspital Graubünden Recruiting Chur, Switzerland, 7000 Contact: Ulrich Mey, MD    +41 81 256 68 85    ulrich.mey@ksgr.ch    Principal Investigator: Ulrich Mey, MD          Hopital Cantonal Universitaire de Geneve Recruiting Geneva, Switzerland, CH-1211 Contact: Nicolas Mach, MD    41-22-372-9881    Nicolas.Mach@hcuge.ch    Principal Investigator: Nicolas Mach, MD          Kantonsspital - St. Gallen Recruiting St. Gallen, Switzerland, CH-9007 Contact: Felicitas Hitz, MD    +41 71 494 11 11    felicitas.hitz@kssg.ch    Principal Investigator: Felicitas Hitz, MD Less <<
NCT02689869 Indolent Non-Hodgkin Lymphoma Phase 2 Active, not recruiting July 2022 Germany ... More >> Klinikum der Universität München München, Bavaria, Germany, 81377 Less <<
NCT01849848 Relapsed/Refractory Multiple M... More >>yeloma Less << Phase 2 Completed - Japan ... More >> Chuo-ku, Japan Fukuoka, Japan Isehara, Japan Koto-ku, Japan Kyoto, Japan Nagoya, Japan Niigata, Japan Okayama, Japan Sapporo, Japan Sendai, Japan Shibukawa, Japan Shibuya-ku, Japan Tokushima, Japan Utsunomiya, Japan Less <<
NCT03671018 B-cell Non-Hodgkin Lymphoma Phase 1 Recruiting September 28, 2023 United States, California ... More >> City of Hope Recruiting Duarte, California, United States, 91010 United States, Florida University of Miami Miller School of Medicine Recruiting Miami, Florida, United States, 33136 Less <<
NCT02273856 - Terminated(The study was termi... More >>nated due to insufficient subject enrollment and very slow enrollment.) Less << - Jordan ... More >> Site JO96201 King Abdullah University Hospital Irbid, Jordan, 22110 Kuwait Site KW96501 Kuwait Cancer Control Center Shuwaikh, Kuwait, 70653 Lebanon Site Hammoud Hospital University Medical Center Beirut, Lebanon, 1600 Site Hotel Dieu De France Beirut, Lebanon, 166830 Oman Site OM96801 Sultan Qaboos University Hospital Muscat, Oman, 123 Qatar Site Hamad Medical Coorporation, National Center for Cancer Care and Research, Al Amal Hospital Doha, Qatar, 3050 Saudi Arabia Site SA96601 Aseer Central Hospital Abha, Aseer, Saudi Arabia, 61421 United Arab Emirates Site AE97101 Sheikh Khalifa Medical City Abu Dhabi, United Arab Emirates, 51900 Less <<
NCT01849848 - Completed - -
NCT02951156 Diffuse Large B-Cell Lymphoma Phase 3 Active, not recruiting May 29, 2021 -
NCT02950051 Chronic Lymphocytic Leukemia Phase 3 Recruiting January 2024 -
NCT02690545 Lymphoma Lymp... More >>homa, Non-Hodgkin Immune System Diseases Immunoproliferative Disorders Lymphatic Diseases Lymphoproliferative Disorders Neoplasms Neoplasms by Histologic Type Less << Phase 1 Phase 2 Recruiting October 2034 United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Catherine Cheng    919-445-4208    catherine_cheng@med.unc.edu    Contact: Spencer Laing    919-962-8618    ssblaing@email.unc.edu    Principal Investigator: Anne Beaven, MD Less <<
NCT01476787 Follicular Lymphoma Phase 3 Active, not recruiting June 1, 2024 -
NCT01438177 - Terminated(PI left institution... More >>.) Less << - -
NCT01650701 Follicular Lymphoma Phase 3 Active, not recruiting September 2024 -
NCT01488162 - Completed - -
NCT02130869 Neuroblastoma ... More >> Lymphoma High-risk Tumor Less << Phase 1 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT01332968 Non-Hodgkin's Lymphoma Phase 3 Active, not recruiting April 8, 2021 -
NCT00634881 Chronic Lymphocytic Leukemia Phase 1 Phase 2 Completed - Germany ... More >> Medizinische Universitaetsklinik I at the University of Cologne Cologne, Germany, D-50924 Klinikum Barnim GmbH, Werner Forssmann Krankenhaus Eberswalde, Germany, 16225 Universitatsklinikum Heidelberg Heidelberg, Germany, D-69115 Klinikum Lippe - Lemgo Lemgo, Germany, D-32657 III Medizinische Klinik Mannheim Mannheim, Germany, D-68305 Krankenhaus Barmherzige Brueder Regensburg Regensburg, Germany, D-93049 Less <<
NCT03602157 Lymphoma Lymp... More >>homa, Non-Hodgkin Immune System Diseases Immunoproliferative Disorders Lymphatic Diseases Lymphoproliferative Disorders Neoplasms Less << Phase 1 Recruiting May 30, 2036 United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Catherine Cheng    919-445-4208    catherine_cheng@med.unc.edu    Contact: Spencer Laing    919-962-8618    spencer.laing@med.unc.edu Less <<
NCT01332968 - Active, not recruiting - -
NCT01724021 Diffuse Large B-Cell Lymphoma,... More >> Non-Hodgkin's Lymphoma Less << Phase 3 Completed - -
NCT02416206 Multiple Myeloma Phase 2 Recruiting May 2020 United States, Georgia ... More >> Blood and Marrow Transplant Group of Georgia Recruiting Atlanta, Georgia, United States, 30342 Contact: Scott R. Solomon, MD    404-255-1930 Less <<
NCT01088048 Indolent Non-Hodgkin's Lymphom... More >>a Chronic Lymphocytic Leukemia Mantle Cell Lymphoma Less << Phase 1 Completed - United States, Alabama ... More >> Clearview Cancer Institute Huntsville, Alabama, United States, 35805 United States, California UCLA Los Angeles, California, United States, 90024 Stanford Cancer Center Palo Alto, California, United States, 94304-5548 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New York Long Island Jewish Medical Center New Hyde Park, New York, United States, 11040 Weill Medical College of Cornell New York, New York, United States, 10021 United States, Oregon Willamette Valley Cancer Institute and Research Center Springfield, Oregon, United States, 97477 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 United States, Texas MD Anderson Cancer Houston, Texas, United States, 77030 United States, Washington North Star Lodge Cancer Center Yakima, Washington, United States, 98902 Less <<
NCT03187210 Lymphoma Phase 1 Phase 2 Recruiting June 2022 Switzerland ... More >> Department for Medical Oncology University Hospital/Inselspital Recruiting Berne, Switzerland, 3010 Principal Investigator: Thomas Pabst, Prof Dr med Less <<
NCT01889069 Lymphoma Phase 3 Active, not recruiting June 15, 2019 Italy ... More >> Irccs Crob Rionero in Vulture, Basilicata, Italy, 85028 Azienda Ospedaliera Bianchi-Melacrino-Morelli; Unità Operativa di Ematologia Reggio Calabria, Calabria, Italy, 89100 Azienda Ospedaliera S.G. Moscati; Divisione Ematologia Avellino, Campania, Italy, 83100 Asl ce - p.o. Avers; Uoc ematologia Aversa, Campania, Italy, 81031 A.O. San Sebastiano; U.O.C. Oncologia Caserta, Campania, Italy, 81100 Seconda università degli studi di napoli; Medicina clinica e sperimentale magrassi - lanzara Napoli, Campania, Italy, 80138 Osp. Santa Maria Goretti; Ematologia Latina, Lazio, Italy, 04100 Ospedale S. Eugenio; Divisione Di Ematologia Roma, Lazio, Italy, 00144 Regina Elena National Cancer Institute; Hematology Roma, Lazio, Italy, 00144 Az. Osp. S. Camillo Forlanini; Uo Ematologia E Trapianti Di Midollo Osseo Roma, Lazio, Italy, 00152 Universita' Degli Studi La Sapienza-Ist.Di Ematologia; Dip Biot Cel e Ematol Roma, Lazio, Italy, 00161 Azienda Ospedaliera S. Giovanni Addolorata; UOC Ematologia Roma, Lazio, Italy, 00184 ASL Viterbo; Presidio Ospedaliero di Ronciglione; UOC Ematologia Ronciglione, Lazio, Italy, 01037 Ospedale Valduce;U.O.S. Oncologia Ed Ematologia Como, Lombardia, Italy, 22100 ASST DI CREMA; U O Oncologia Medica Crema, Lombardia, Italy, 26013 ASST DI LECCO; Oncologia Medica Lecco, Lombardia, Italy, 23900 Az. Osp. Carlo Poma; Divisione Di Oncologia Medica Mantova, Lombardia, Italy, 46100 Osp. San Raffaele; Dip. Di Oncoematologia Milano, Lombardia, Italy, 20132 Ist. Nazionale Per Lo Studio E Cura Dei Tumori; Div. Ematologia Trapianto Midollo Osseo Allogenico Milano, Lombardia, Italy, 20133 Irccs Policlinico San Matteo; Divisione Di Ematologia Pavia, Lombardia, Italy, 27100 Istituto Clinico Humanitas;U.O. Oncologia Medica Ed Ematologia Rozzano, Lombardia, Italy, 20089 Ospedale Gen.Le Prov.Le 'C.G.Mazzoni'; Ematologia Ascoli Piceno, Marche, Italy, 63100 Ospedale di Civitanova Marche; Medicina Interna Civitanova Marche, Marche, Italy, 62012 Ospedale di Macerata; Medicina Generale Macerata, Marche, Italy, 62100 Università Cattolica Del Sacro Cuore S.S. Giovanni Paolo Ii; Uoc Di Onco-Ematologia Campobasso, Molise, Italy, 86100 Ospedale Civile SS. Antonio E Biagio DI Alessandria; Ematologia Alessandria, Piemonte, Italy, 15121 Univ. Piemonte Est Amedeo Avogadro; Div.Ematologia- Dip.Clinica Med.Sperim.& Ircad Novara, Piemonte, Italy, 28100 Irccs Ist. Tumori Giovanni Paolo Ii; Dipartimento Oncologia Medica Bari, Puglia, Italy, 70124 Azienda ospedaliera oo rr di foggi; Hematology Foggia, Puglia, Italy, 71100 Ospedale S.Nicola Pellegrino; Reparto Di Ematologia Trani, Puglia, Italy, 70059 Ospedale Roberto Binaghi; Centro trapianti di midollo osseo Cagliari, Sardegna, Italy, 09126 Osp. San Francesco; Ematologia e CTMO Nuoro, Sardegna, Italy, 08100 ARNAS Garibaldi; Ematologia Catania, Sicilia, Italy, 95122 Az. Osp. Papardo; Struttura Complessa Di Ematologia Messina, Sicilia, Italy, 98165 ARNAS-Ospedale Civico Maurizio Ascoli; Unità Operativa di Oncologia Medica Palermo, Sicilia, Italy, 90127 Azienda Uni Ria Policlinico P. Giaccone ; Divisione Di Ematologia E Trapianto Palermo, Sicilia, Italy, 90127 Ospedale Santa Chiara; Unita Operativa Di Ematologia Pisa, Toscana, Italy, 56100 USL 4 di Prato - Nuovo Ospeale di Prato Prato, Toscana, Italy, 59100 A.O. Santa Maria Terni; S.C. Oncoematologia Terni, Umbria, Italy, 05100 IOV - Istituto Oncologico Veneto - IRCCS; Oncologia Medica II Padova, Veneto, Italy, 35128 Less <<
NCT01905943 Chronic Lymphocytic Leukemia Phase 3 Completed - -
NCT02063685 Follicular Non-Hodgkin's Lymph... More >>oma Less << Phase 3 Active, not recruiting December 2021 -
NCT02134262 Relapsed or Refractory B-Cell ... More >>Non-Hodgkin Lymphoma Less << Phase 1 Phase 2 Unknown March 2017 Japan ... More >> Jichi Medical University Recruiting Shimotsuke, Tochigi, Japan, 329-0498 Contact: Ken Ohmine, MD, PhD    +81-285-58-7353    omineken@jichi.ac.jp    Principal Investigator: Keiya Ozawa, MD, PhD Less <<
NCT01724021 - Completed - -
NCT03593018 Relapsed Angioimmunoblastic T-... More >>Cell Lymphoma Refractory Angioimmunoblastic T-cell Lymphoma Less << Phase 3 Recruiting December 2021 Belgium ... More >> A. Z. Sint-Jan Brugge-Oostende AV Recruiting Bruges, Belgium Contact: Sylvia SNAUWAERT, MD          Cliniques Universitaires de Bruxelles - Hôpital Erasme Recruiting Bruxelles, Belgium Contact: Alice WOLFROMM, MD          Université Catholique de Louvain Saint-Luc Recruiting Bruxelles, Belgium Contact: Nicole STRAETMANS, MD          CHU de Liège Recruiting Liège, Belgium Contact: Christophe BONNET, MD          CHU UCL Namur - Site Godinne Recruiting Yvoir, Belgium Contact: Marc ANDRE, MD          France Institut d'Hématologie de Basse Normandie Recruiting Caen, France Contact: Gandhi DAMAJ, MD          CHU de Clermont-Ferrand - Hôpital Estaing Recruiting Clermont-Ferrand, France Contact: Olivier TOURNILHAC, MD          CHU Henri Mondor Recruiting Créteil, France Contact: Jehan DUPUIS, MD          CHU de Dijon Recruiting Dijon, France Contact: Olivier CASASNOVAS, MD          CHU de Grenoble Recruiting Grenoble, France Contact: Rémy GRESSIN, MD          CHRU de Lille Recruiting Lille, France Contact: Franck MORSCHHAUSER, MD          CHU de Limoges Recruiting Limoges, France Contact: Céline KENNEL, MD          CHU de Montpellier - Hôpital Saint-Eloi Recruiting Montpellier, France Contact: Guillaume CARTRON, MD          CHU de Nantes - Hôtel Dieu Recruiting Nantes, France Contact: Steven LE GOUILL, MD          Hôpital Necker Recruiting Paris, France Contact: Richard DELARUE, MD          Hôpital Saint-Louis Recruiting Paris, France Contact: Catherine THIEBLEMONT, MD          CHU Haut-Lévèque - Centre François Magendie Recruiting Pessac, France Contact: Kamal BOUABDALLAH, MD          CHU Lyon-Sud Recruiting Pierre-Bénite, France Contact: Emmanuel BACHY, MD          CH Annecy Genevois Recruiting Pringy, France Contact: Nicolas DAGUINDAU, MD          CHU Pontchaillou Recruiting Rennes, France Contact: Roch HOUOT, MD          Centre Henri Becquerel Recruiting Rouen, France Contact: Hervé TILLY, MD          IUCT - Oncopole Recruiting Toulouse, France Contact: Loïc YSEBAERT, MD          CHRU de Nancy - Hôpital de Brabois Recruiting Vandœuvre-lès-Nancy, France Contact: Lauriane CLEMENT-FILLIATRE, MD Less <<
NCT02194374 Leukemia Phase 1 Withdrawn(Study closed with no... More >> enrollment due to unavailability of reagent.) Less << - -
NCT02153580 Post-transplant Lymphoprolifer... More >>ative Disorder B-Cell Prolymphocytic Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Hairy Cell Leukemia B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma Recurrent Lymphoplasmacytic Lymphoma Less << Phase 1 Recruiting December 2021 United States, California ... More >> City of Hope Medical Center Recruiting Duarte, California, United States, 91010 Contact: Tanya Siddiqi    800-826-4673       Principal Investigator: Tanya Siddiqi Less <<
NCT00877214 Follicular Lymphomas ... More >> Immunocytomas Marginal Zone Lymphomas Mantle-Cell Lymphomas Lymphocytic Lymphoma Non-Hodgkin's Lymphoma Less << Phase 3 Active, not recruiting April 2022 Germany ... More >> StiL Head Office; Justus-Liebig-University Giessen, Germany, 35392 Less <<
NCT00385125 Lymphoma, High-Grade Phase 2 Unknown - Germany ... More >> University of Magdeburg, departement of Hematology and Oncology Recruiting Magdeburg, Germany, 39120 Principal Investigator: Martin Mohren, PD Less <<
NCT03269669 Grade 1 Follicular Lymphoma ... More >> Grade 2 Follicular Lymphoma Grade 3a Follicular Lymphoma Recurrent Follicular Lymphoma Refractory Follicular Lymphoma Less << Phase 2 Recruiting December 31, 2022 -
NCT03755804 Hodgkin Lymphoma Phase 2 Recruiting July 1, 2028 United States, Tennessee ... More >> St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Jamie Flerlage, MD, MS    866-278-5833    referralinfo@stjude.org Less <<
NCT01905943 - Completed - -
NCT02278796 Lymphoma, Large B-Cell, Diffus... More >>e Lymphoma, Follicular Lymphoma, Mantle-Cell Less << Phase 2 Active, not recruiting December 2019 Austria ... More >> Krankenhaus der Elisabethinen Linz Linz, Austria, 4020 Hanusch Krankenhaus Wien Wien, Austria, 1140 Switzerland Department for Medical Oncology University Hospital/Inselspital Berne, Switzerland, 3010 Universitätsspital Zürich Zürich, Switzerland, 8091 Less <<
NCT02626455 Lymphoma, Non-Hodgkin Phase 3 Recruiting December 31, 2024 -
NCT02467946 Clinical Efficacy ... More >> Safety Less << Phase 1 Phase 2 Recruiting December 2021 France ... More >> Centre Antoine Lacassagne Recruiting Nice, France, 06000 Contact: Antoine THYSS, Phd    +33492031497    antoine.thyss@nice.unicancer.fr    Contact: LOVERA Christine    +33492031618    christine.lovera@nice.unicancer.fr    Principal Investigator: Simonetta VIVIANI, Phd Less <<
NCT01716806 Hodgkin Disease Phase 2 Recruiting July 2021 -
NCT02733042 Lymphoma Leuk... More >>emia, Lymphocytic, Chronic, B-Cell Less << Phase 1 Phase 2 Active, not recruiting July 8, 2022 -
NCT01831505 Lymphoma Phase 1 Completed - United States, Washington ... More >> Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 Less <<
NCT03696784 Lymphoma Lymp... More >>homa, B-Cell Immune System Diseases Immunoproliferative Disorders Lymphatic Diseases Less << Phase 1 Not yet recruiting October 30, 2033 United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Not yet recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Catherine Cheng    919-445-4208    catherine_cheng@med.unc.edu    Contact: Spencer Laing    919-962-8618    ssblaing@email.unc.edu    Principal Investigator: Grover Natalie, MD Less <<
NCT01232556 Lymphoma, Non-Hodgkin Phase 3 Terminated(The study was termi... More >>nated prematurely on May 16, 2013, for futility. No new or unexpected safety issues were identified.) Less << - -
NCT01490723 Leukemia Lymp... More >>homa Less << Phase 2 Active, not recruiting January 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00794638 Non-Hodgkin's Lymphoma ... More >> Diffuse Large B-cell Lymphoma Mantle Cell Lymphoma Follicular Lymphoma Less << Phase 1 Completed - Japan ... More >> Nagoya-city, Aichi, Japan Isehara-city, Kanagawa, Japan Kyoto-city, Kyoto, Japan Chuo-ku, Tokyo, Japan Less <<
NCT01232556 - Terminated(The study was termi... More >>nated prematurely on May 16, 2013, for futility. No new or unexpected safety issues were identified.) Less << - -
NCT01457144 Mantle Cell Lymphoma Phase 2 Completed - France ... More >> Valerie ROLLAND NEYRET Grenoble, France, 38043 Less <<
NCT00825149 Non-Hodgkin's Lymphoma Phase 1 Completed - -
NCT01118845 - Completed - -
NCT01644253 Chronic Lymphocytic Leukemia ... More >> Peripheral T-cell Lymphoma Less << Phase 1 Active, not recruiting December 2019 United States, Georgia ... More >> Augusta, Georgia, United States, 30912 United States, Ohio Columbus, Ohio, United States, 43210 United States, South Carolina Greenville Health System Greenville, South Carolina, United States, 29605 United States, Texas Houston, Texas, United States, 77030 United States, Washington Swedish Cancer Institute,1221 Madison St. Seattle, Washington, United States, 98104 Less <<
NCT01300247 Lymphocytic Leukemia, Chronic Phase 1 Completed - United States, Alabama ... More >> Huntsville, Alabama, United States, 35805 United States, California Duarte, California, United States, 91010 La Jolla, California, United States, 92093 Los Angeles, California, United States, 90095 United States, Connecticut Southington, Connecticut, United States, 06489 United States, Florida Tampa, Florida, United States, 33612-9497 United States, Georgia Atlanta, Georgia, United States, 30322 Marietta, Georgia, United States, 30060 United States, Illinois Chicago, Illinois, United States, 60637 United States, Maryland Boston, Maryland, United States, 02115 United States, Massachusetts Boston, Massachusetts, United States, 02114 United States, Minnesota St. Louis Park, Minnesota, United States, 55426 United States, Missouri Springfield, Missouri, United States, 65807 United States, New York Rochester, New York, United States, 14642 United States, Texas Houston, Texas, United States, 77030 United States, Washington Seattle, Washington, United States, 98109 Tacoma, Washington, United States, 98405 United States, Wisconsin Madison, Wisconsin, United States, 53705 Less <<
NCT01118845 Non-Hodgkin's Lymphoma ... More >> Lymphoma, Large Cell Diffuse, Mantle Cell Lymphoma, Lymphoma Follicular Lymphoma Large B-Cell, Diffuse Less << Phase 2 Completed - Japan ... More >> Nagoya, Aichi, Japan Matsuyama, Ehime, Japan Kurume, Fukuoka, Japan Maebashi, Gunma, Japan Sapporo, Hokkaido, Japan Kanazawa, Ishikawa, Japan Isehara, Kanagawa, Japan Ninomaru, Kumamoto, Japan Sendai, Miyagi, Japan Kita-ku, Okayama, Japan Kurashiki, Okayama, Japan Hidaka, Saitama, Japan Izumo, Shimane, Japan Chuo-ku, Tokyo, Japan Akita, Japan Fukuoka, Japan Kagoshima, Japan Kyoto, Japan Korea, Republic of Seo-gu, Busan, Korea, Republic of Jung-gu, Daegu, Korea, Republic of Goyang-si, Gyeonggi-do, Korea, Republic of Hwasun-gun, Jeonnam, Korea, Republic of Gangnam-gu, Seoul, Korea, Republic of Seodaemun-gu, Seoul, Korea, Republic of Songpa-gu, Seoul, Korea, Republic of Less <<
NCT01292135 B-cell Chronic Lymphocytic Leu... More >>kemia Small Lymphocytic Lymphoma Less << Phase 1 Completed - United States, Massachusetts ... More >> Dana Farber Cancer Center Boston, Massachusetts, United States, 02115 United States, New York CLL Research and Treatment Program New Hyde Park, New York, United States, 11042 Weill Medical College of Cornell University New York, New York, United States, 10065 University of Rochester Rochester, New York, United States, 14642 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 United States, Texas MD Anderson Houston, Texas, United States, 77030 Less <<
NCT01300247 - Completed - -
NCT02414022 - Active, not recruiting December 2020 Canada, Ontario ... More >> Stronach Regional Health Centre at Southlake Newmarket, Ontario, Canada, L3Y 2P9 Less <<
NCT01179490 Multiple Myeloma Phase 2 Terminated - Japan ... More >> Research site Nagoya, Aichi, Japan Research site Isehara, Kanagawa, Japan Research site Fukuoka, Japan Less <<
NCT01179490 - Terminated - -
NCT00740415 Lymphoma Phase 2 Completed - France ... More >> CHU de Grenoble - Hopital Michallon Grenoble, France, 38043 Less <<
NCT01678430 Chronic Lymphocytic Leukaemia Phase 3 Unknown December 2017 United Kingdom ... More >> Countess of Chester Hospital Recruiting Chester, Cheshire, United Kingdom Principal Investigator: Salaheddin Tueger          Derriford Hospital Recruiting Plymouth, Devon, United Kingdom Principal Investigator: Simon Rule          Torbay Hospital Recruiting Torquay, Devon, United Kingdom Principal Investigator: Deborah Turner          Royal Bournemouth Hospital Recruiting Bournemouth, Dorset, United Kingdom Principal Investigator: Helen McCarthy          Dorset County Hospital Recruiting Dorchester, Dorset, United Kingdom Principal Investigator: Akeel Moosa          Colchester General Hospital Recruiting Colchester, Essex, United Kingdom Principal Investigator: Mike Hamblin          Basingstoke and North Hampshire Hospital Recruiting Basingstoke, Hampshire, United Kingdom Principal Investigator: Sylwia Simpson          Southampton General Hospital Recruiting Southampton, Hampshire, United Kingdom Principal Investigator: Andrew Duncombe          Barnet and Chase Farm Hospitals Recruiting Enfield, Hertfordshire, United Kingdom Principal Investigator: Andres Virchis          Kent and Canterbury Hospital Recruiting Canterbury, Kent, United Kingdom Principal Investigator: Christopher Pocock          Maidstone Hospital Recruiting Maidstone, Kent, United Kingdom Principal Investigator: Saad Rassam          Princess Royal Hospital Recruiting Orpington, Kent, United Kingdom Principal Investigator: Corrine De Lord          Queen Elizabeth Hospital Recruiting Woolwich, London, United Kingdom Principal Investigator: Corrine De Lord          West Middlesex University Hospital Recruiting Isleworth, Middlesex, United Kingdom Principal Investigator: Magda Alobaidi          Ealing Hospital Recruiting Southall, Middlesex, United Kingdom Principal Investigator: Richard Kaczmarski          Hillingdon Hospital Recruiting Uxbridge, Middlesex, United Kingdom Principal Investigator: Richard Kaczmarski          Belfast City Hospital Recruiting Belfast, Northern Ireland, United Kingdom Principal Investigator: Paul Kettle          Royal United Hospital Recruiting Bath, Somerset, United Kingdom Principal Investigator: Christopher Knechtli          Weston General Hospital Recruiting Weston-super-Mare, Somerset, United Kingdom Principal Investigator: Philip Robson          Queens Hospital Recruiting Burton-upon-Trent, Staffordshire, United Kingdom Principal Investigator: Humayun Ahmad          Queen Elizabeth Hospital Recruiting Gateshead, Tyne and Wear, United Kingdom Principal Investigator: Scott Marshall          Queen Elizabeth Hospital Recruiting Birmingham, West Midlands, United Kingdom Principal Investigator: Paul Moss          Bradford Royal Infirmary Recruiting Bradford, West Yorkshire, United Kingdom Principal Investigator: Adrian Williams          Airdale General Hospital Recruiting Keighley, West Yorkshire, United Kingdom Principal Investigator: Chetan Patalappa          St James University Hospital Recruiting Leeds, West Yorkshire, United Kingdom Principal Investigator: Peter Hillmen          Salisbury District Hospital Recruiting Salisbury, Wiltshire, United Kingdom Principal Investigator: Jonathan Cullis          Arrowe Park Hospital Recruiting Upton, Wirral, United Kingdom Principal Investigator: Ranjit Dasgupta          Royal Liverpool Hospital Recruiting Liverpool, United Kingdom Principal Investigator: Andrew Pettitt Less <<
NCT02056756 Multiple Myeloma Phase 1 Phase 2 Active, not recruiting February 2021 Germany ... More >> Universitätsklinikum Schleswig-Holstein (UKSH) - Division of Stem Cell Transplantation and Immunotherapy, 2nd Department of Medicine Kiel, Germany, 24105 Italy Fo.NE.Sa. Onlus Torino, TO, Italy, 10126 Divisione di Ematologia A.O.U. Ospedali Riuniti Umberto I - G.M. Lancisi - G. Salesi di Ancona Ancona, Italy, 60126 Less <<
NCT00769522 Chronic Lymphocytic Leukemia Phase 3 Completed - Germany ... More >> Medizinische Universitaetsklinik I at the University of Cologne Cologne, Germany, D-50924 Less <<
NCT01664910 Lymphoma Leuk... More >>emia Less << Phase 1 Phase 2 Recruiting October 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT01376401 Multiple Myeloma Phase 2 Completed - Spain ... More >> Hospital Germans Trias i Pujol Badalona, Barcelona, Spain Hospital Clínic Barcelona, Spain Institut català d'Oncología Barcelona, Spain Hospital 12 de Octubre Madrid, Spain Hospital Clínico San Carlos Madrid, Spain Hospital Universitario de la Princesa Madrid, Spain Hospital Universitario Ramón y Cajal Madrid, Spain MD Anderson Internacional Madrid, Spain Hospital General Morales Messeguer Murcia, Spain Hospital Universitario Virgen de la Victoria Málaga, Spain Hospital Universitario Central de Asturias Oviedo, Spain Hospital Universitario Virgen del Rocío Sevilla, Spain Hospital Universitario La Fe Valencia, Spain Hospital Clinico Universitario Lozano Blesa Zaragoza, Spain Less <<
NCT02424851 Multiple Myeloma ... More >> Chronic Kidney Disease Less << Phase 2 Recruiting June 2019 United Kingdom ... More >> Basingstoke & North Hampshire Hospital Not yet recruiting Basingstoke, United Kingdom Principal Investigator: Noel Ryman          Kent & Canterbury Hospital Recruiting Canterbury, United Kingdom, CT1 3NG Principal Investigator: Jindrinska Lindsay          St Helier Hospital Recruiting Epsom, United Kingdom Principal Investigator: Simon Stern          Royal Liverpool Hospital Recruiting Liverpool, United Kingdom Principal Investigator: Nauman Butt          Churchill Hospital Recruiting Oxford, United Kingdom, OX3 7LE Principal Investigator: Karthik Ramasamy          Queen Alexandra Hospital Recruiting Portsmouth, United Kingdom Contact: Helen Dignum          Principal Investigator: Helen Dignum          Great Western Hospital Suspended Swindon, United Kingdom Less <<
NCT02927769 Hodgkin Disease Phase 2 Recruiting March 27, 2022 -
NCT03524235 Multiple Myeloma ... More >> CLL Chronic Lymphocytic Leukemia Lymphoma Less << Phase 1 Recruiting May 2023 United States, California ... More >> Cedars Sinai Medical Center Recruiting Los Angeles, California, United States, 90048 Contact: Hannah Coleman    310-967-4376    hannah.coleman@cshs.org Less <<
NCT03567876 Lymphoma, Mantle-Cell Phase 2 Not yet recruiting July 2025 Italy ... More >> A.O. SS. Antonio e Biagio e Cesare Arrigo, SC Ematologia Not yet recruiting Alessandria, Italy Contact: Marco Ladetto       marco.ladetto@ospedale.al.it    Principal Investigator: Marco Ladetto, MD          Università Politecnica delle Marche, Clinica di Ematologia Not yet recruiting Ancona, Italy Contact: Guido Gini       guido.gini@ospedaliriuniti.marche.it    Principal Investigator: Guido Gini, MD          Centro Riferimento Oncologico, S.O.C. Oncologia Medica A Not yet recruiting Aviano, Italy Contact: Michele Spina       mspina@cro.it    Principal Investigator: Michele Spina, MD          IRCCS Istituto Tumori Giovanni Paolo II, UOC Ematologia Not yet recruiting Bari, Italy Contact: Giacomo Loseto       loseto.giacomo@gmail.com    Principal Investigator: Giacomo Loseto, MD          Policlinico S. Orsola-Malpighi, Istituto di Ematologia "Seragnoli" Not yet recruiting Bologna, Italy Contact: Pier Luigi Zinzani       pierluigi.zinzani@unibo.it    Principal Investigator: Pier Luigi Zinzani, Prof          Ospedale Centrale di Bolzano, Divisione di Ematologia e T.M.O. Not yet recruiting Bolzano, Italy Contact: Michael Mian       michael.mian@asbz.it    Principal Investigator: Michael Mian, Prof          ASST Spedali Civili, Ematologia Not yet recruiting Brescia, Italy Contact: Alessandro Re       alessandro.re@asst-spedalicivili.it    Principal Investigator: Alessandro Re, MD          Ospedale Businco, Ematologia Not yet recruiting Cagliari, Italy Contact: Maria Giuseppina Cabras       cabras.giuseppina@tiscali.it    Principal Investigator: Maria Giuseppina Cabras, MD          Azienda Ospedaliera di Cosenza, UOC Ematologia Not yet recruiting Cosenza, Italy Contact: Massimo Gentile       massimogentile@virgilio.it    Principal Investigator: Massimo Gentile, MD          Azienda Ospedaliera S. Croce e Carle, SC Ematologia Not yet recruiting Cuneo, Italy Contact: Claudia Castellino       castellino.c@ospedale.cuneo.it    Principal Investigator: Claudia Castellino, MD          Azienda Ospedaliera Universitaria Careggi, Unità funzionale di Ematologia Not yet recruiting Firenze, Italy Contact: Luigi Rigacci       luigi.rigacci@unifi.it    Principal Investigator: Luigi Rigacci, MD          Ospedale Policlinico San Martino S.S.R.L. - IRCCS per l'Oncologia, Clinica Ematologica Not yet recruiting Genova, Italy Contact: Marco Gobbi       gobbi@unige.it    Principal Investigator: Marco Gobbi, Prof          Ospedale Policlinico San Martino S.S.R.L. - IRCCS per l'Oncologia, Ematologia Not yet recruiting Genova, Italy Contact: Angela Giovanna Congiu       angelagiovanna.congiu@hsanmartino.it    Principal Investigator: Angela Giovanna Congiu, MD          Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.), Ematologia Not yet recruiting Meldola, Italy Contact: Gerardo Musuraca       g.musuraca@irst.emr.it    Principal Investigator: Gerardo Musuraca, MD          ASST Grande Ospedale Metropolitano Niguarda, SC Ematologia Not yet recruiting Milano, Italy Contact: Vittorio Ruggero Zilioli       vittorioruggero.zilioli@ospedaleniguarda.it    Principal Investigator: Vittorio Ruggero Zilioli, MD          Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Ematologia Not yet recruiting Milano, Italy Contact: Paolo Corradini       paolo.corradini@unimi.it    Principal Investigator: Paolo Corradini, Prof          Istituto Scientifico San Raffaele, Unità Linfomi - Dipartimento Oncoematologia Not yet recruiting Milano, Italy Contact: Andrés Ferreri       andres.ferreri@hsr.it    Principal Investigator: Andrés Ferreri, MD          Ospedale Maggiore Policlinico - Fondazione IRCCS Ca' Granda, Ematologia Not yet recruiting Milano, Italy Contact: Luca Baldini       luca.baldini@unimi.it    Principal Investigator: Luca Baldini, Prof          AOU Maggiore della Carità di Novara, SCDU Ematologia Not yet recruiting Novara, Italy Contact: Luca Nassi       luca.nassi@med.uniupo.it    Principal Investigator: Luca Nassi, MD          Azienda Ospedaliera Universitaria di Padova, Ematologia Not yet recruiting Padova, Italy Contact: Francesco Piazza       francesco.piazza@unipd.it    Principal Investigator: Francesco Piazza, MD          A.O. Ospedali Riuniti Villa Sofia-Cervello, Divisione di Ematologia Not yet recruiting Palermo, Italy Contact: Caterina Patti       k.patti@villasofia.it    Principal Investigator: Caterina Patti, MD          IRCCS Policlinico S. Matteo, Divisione di Ematologia Not yet recruiting Pavia, Italy Contact: Luca Arcaini       luca.arcaini@unipv.it    Principal Investigator: Luca Arcaini, Prof          Ospedale Guglielmo Da Saliceto, UO Ematologia Not yet recruiting Piacenza, Italy Contact: Annalisa Arcari       a.arcari@ausl.pc.it    Principal Investigator: Annalisa Arcari, MD          Ospedale delle Croci, Ematologia Not yet recruiting Ravenna, Italy Contact: Monica Tani       monica.tani@auslromagna.it    Principal Investigator: Monica Tani, MD          Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Ematologia Not yet recruiting Reggio Calabria, Italy Contact: Caterina Stelitano       caterinastelitano27@gmail.com    Principal Investigator: Caterina Stelitano, MD          Azienda Unità Sanitaria Locale-IRCCS - Arcispedale Santa Maria Nuova, Ematologia Not yet recruiting Reggio Emilia, Italy Contact: Francesco Merli       merli.francesco@ausl.re.it    Principal Investigator: Francesco Merli, MD          Ospedale degli Infermi, UO Ematologia Not yet recruiting Rimini, Italy Contact: Annalia Molinari       annalia.molinari@auslromagna.it    Principal Investigator: Annalia Molinari, MD          Policlinico Umberto I - Università "La Sapienza", Istituto Ematologia -Dipartimento di Biotecnologie Cellulari ed Ematologia Not yet recruiting Roma, Italy Contact: Maurizio Martelli       martelli@bce.uniroma1.it    Principal Investigator: Maurizio Martelli, Prof          Università Cattolica S. Cuore, Ematologia Not yet recruiting Roma, Italy Contact: Stefan Hohaus       stefan.hohaus@Unicatt.it    Principal Investigator: Stefan Hohaus, MD          Istituto Clinico Humanitas, UO Ematologia Not yet recruiting Rozzano, Italy Contact: Armando Santoro       armando.santoro@cancercenter.humanitas.it    Principal Investigator: Armando Santoro, MD          Casa Sollievo della Sofferenza, UO Ematologia Not yet recruiting San Giovanni Rotondo, Italy Contact: Nicola Cascavilla       n.cascavilla@operapadrepio.it    Principal Investigator: Nicola Cascavilla, MD          Azienda Ospedaliero Universitaria Senese, UOC Ematologia Not yet recruiting Siena, Italy Contact: Alberto Fabbri       fabbri7@unisi.it    Principal Investigator: Alberto Fabbri, MD          A.O.U. Città della Salute e della Scienza di Torino, SC Ematologia Universitaria Not yet recruiting Torino, Italy Contact: Federica Cavallo       f.cavallo@unito.it    Principal Investigator: Federica Cavallo, MD          A.O.U. Città della Salute e della Scienza di Torino, SC Ematologia Not yet recruiting Torino, Italy Contact: Annalisa Chiappella       achiappella@cittadellasalute.to.it    Principal Investigator: Annalisa Chiappella, MD          Ospedale Ca' Foncello, SC Ematologia Not yet recruiting Treviso, Italy Contact: Piero Maria Stefani       pmstefani@ulss.tv.it    Principal Investigator: Piero Maria Stefani, MD          Azienda Ospedaliera C. Panico, UOC Ematologia e Trapianto Not yet recruiting Tricase, Italy Contact: Vincenzo Pavone       salentoematologia@piafondazionepanico.it    Principal Investigator: Vincenzo Pavone, MD          Azienda Sanitaria Universitaria Integrata di Udine, Clinica Ematologica Not yet recruiting Udine, Italy Contact: Francesco Zaja       francesco.zaja@asuiud.sanita.fvg.it    Principal Investigator: Francesco Zaja, Prof          Ospedale di Circolo, UOC Ematologia Not yet recruiting Varese, Italy Contact: Michele Merli       michelepavia@hotmail.com    Principal Investigator: Michele Merli, MD          Azienda Ospedaliera Universitaria Integrata di Verona, UO Ematologia Not yet recruiting Verona, Italy Contact: Fabio Benedetti       fabio.benedetti@univr.it    Principal Investigator: Fabio Benedetti, MD          Ospedale San Bortolo, Divisione di Ematologia Not yet recruiting Vicenza, Italy Contact: Carlo Visco       carlo.visco@aulss8.veneto.it    Principal Investigator: Carlo Visco, MD Less <<
NCT00868413 Chronic Lymphocytic Leukemia Phase 1 Completed - United States, California ... More >> Site Reference ID/Investigator# 17841 La Jolla, California, United States, 92093 Site Reference ID/Investigator# 25899 Stanford, California, United States, 94305-5821 United States, Maryland Site Reference ID/Investigator# 21622 Baltimore, Maryland, United States, 21231-1000 United States, Ohio Site Reference ID/Investigator# 21621 Columbus, Ohio, United States, 43210 United States, Pennsylvania Site Reference ID/Investigator# 39613 Philadelphia, Pennsylvania, United States, 19111 United States, Texas Site Reference ID/Investigator# 17943 Houston, Texas, United States, 77030-4009 Less <<
NCT03315520 Relapsed/Refractory Malignant ... More >>Lymphomas Less << Phase 2 Recruiting December 31, 2020 Russian Federation ... More >> The Federal Budget-Funded Institution National Medical Surgical Center named after N. I. Pirogov of the Ministry of health of the Russian Federation Recruiting Moscow, Russian Federation, 105203 Contact: Vladislav Sarzhevskiy, MD, PhD    +74956037217    vladsar100@gmail.com    Contact: Nikita Mochkin, MD, PhD    +74956037217    nickmed@yandex.ru Less <<
NCT01275209 Follicular Lymphoma Phase 1 Completed - United States, Massachusetts ... More >> Dana Farber Cancer Institute SC-5 Boston, Massachusetts, United States, 02115 United States, Michigan Wayne State University/Karmanos Cancer Institute Dept.of KarmanosCancerInst (6) Detroit, Michigan, United States, 48201 United States, North Carolina Duke University Medical Center Duke Hem & Onc Durham, North Carolina, United States, 27710 United States, Tennessee Sarah Cannon Research Institute SC - 2 Chattanooga, Tennessee, United States, 37404 Australia, Victoria Novartis Investigative Site Prahran, Victoria, Australia, 3181 Belgium Novartis Investigative Site Gent, Belgium, 9000 Novartis Investigative Site Leuven, Belgium, 3000 Canada, Ontario Novartis Investigative Site Toronto, Ontario, Canada, M5G 2M9 France Novartis Investigative Site Paris, France, 75475 Italy Novartis Investigative Site Torino, TO, Italy, 10126 Spain Novartis Investigative Site Barcelona, Cataluña, Spain, 08035 Novartis Investigative Site Madrid, Spain, 28046 Less <<
NCT01486797 Chronic Lymphocytic Leukemia Phase 2 Completed - Austria ... More >> Medical University Innsbruck, Division of Hematology and Oncology Innsbruck, Austria University Hospital Salzburg, Department of Medicine III, Center of Oncology and Hematology Salzburg, Austria Landeskrankenhaus Steyr, Department of Internal Medicine II (Hematology and Oncology) Steyr, Austria Hospital Wels-Grieskrichen, Department of Internal Medicine IV (Hematology and Oncology) Wels, Austria Belgium Cliniques universitaires Saint-Luc Brussels, Belgium Institute Jules Bordet, Department of Hematology Brussels, Belgium University Hospital Gasthuisberg, Department of Hematology Leuven, Belgium France Centre Hospitalier Universitaire Clémenceau, Department of Hematology Caen, France Hospices Civils, Department of Hematology Lyon, France Centre Hospitalier Universitaire de la Milétrie, Department of Hematology Poitiers, France Italy University Hospital, Institute of Hematology and Oncology Bologna, Italy Azienda Sanitaria Locale 8, Department of Oncology Cagliari, Italy University Hospital San Martino, Department of Hematology and Oncology Genova, Italy Niguarda Ca'Granda Hospital Milano, Italy University Scientific Research Institute San Raffaele Milano, Italy University School of Medicine, Department of Hematology Padova, Italy University La Sapienza, Department of Cellular Biotechnologies and Hematology Rome, Italy Less <<
NCT02596971 Diffuse Large B-Cell Lymphoma,... More >> Lymphoma Follicular Less << Phase 1 Phase 2 Active, not recruiting April 17, 2020 United States, Colorado ... More >> Rocky Mountain Cancer Center - Aurora Aurora, Colorado, United States, 80012 United States, District of Columbia Georgetown University Medical Center Washington, District of Columbia, United States, 20007 United States, Florida University Miami Miami, Florida, United States, 33136 United States, New York New York Uni Medical Center New York, New York, United States, 10016 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, Oregon Oncology Associates of Oregon, P.C.; Willamette Valley Cancer Institute Springfield, Oregon, United States, 97477 United States, Pennsylvania Western Pennsylvania Hospital Pittsburgh, Pennsylvania, United States, 15224 United States, Texas Texas Oncology Austin, Texas, United States, 78705 Texas Oncology-Tyler Irving, Texas, United States, 75063 Australia, New South Wales Concord Repatriation General Hospital; Haematology Sydney, New South Wales, Australia, 2139 Calvary Mater Newcastle Waratah, New South Wales, Australia, 2298 Australia, Queensland Royal Brisbane Hospital Brisbane, Queensland, Australia, 4029 Australia, South Australia The Queen Elizabeth Hospital; Haematology/Oncology Woodville South, South Australia, Australia, 5011 Australia, Victoria Monash Medical Centre Clayton, Victoria, Australia, 3168 Austin Hospital Heidelberg, Victoria, Australia, 3084 Italy Azienda Ospedaliera S. Orsola-Malpighi Bologna, Emilia-Romagna, Italy, 40138 Istituto Scientifico Romagnolo Per Lo Studio e La Cura Dei Tumori Meldola, Emilia-Romagna, Italy, 47014 Az. Osp. S. Maria Delle Croci; U.O. Di Ematologia Ravenna, Emilia-Romagna, Italy, 48100 Ospedale Infermi di Rimini Rimini, Emilia-Romagna, Italy, 47900 AOU Città della Salute e della Scienza di Torino - Presidio Le Molinette Torino, Lazio, Italy, 10126 Asst Papa Giovanni XXIII Bergamo, Lombardia, Italy, 24100 Azienda Ospedaliera Univ Firenze, Toscana, Italy, 50141 Less <<
NCT01292135 - Completed - -
NCT01465230 - Terminated(This study was unsu... More >>ccessful in enrolling the target number of subjects during the funding period.) Less << - -
NCT02678299 Malignant Lymphoma Phase 1 Phase 2 Recruiting - Denmark ... More >> Department of Hematology, Aarhus University Hospital Recruiting Aarhus, Denmark, DK-8000 Contact: Francesco d'Amore, MD DMSci       frandamo@rm.dk Less <<
NCT02758925 Diffuse Large B Cell Lymphoma Phase 2 Unknown December 2018 -
NCT01244451 Patients With CLL Relapsing Af... More >>ter an Initial Response (CR, PR ≥ 6 Months) Following no More Than Two Prior Treatment Lines; or Patients With CLL Refractory (SD, PD or CR/PR < 6 Months) Following no More Than Two Prior Treatment Lines Less << Phase 2 Completed - Italy ... More >> Dipartimento Area Medica - Presidio Ospedaliero "C. e G.Mazzoni" Ascoli, Italy Unità Operativa Ematologia 1 - Università degli Studi di Bari Bari, Italy, 70010 Ist.Ematologia e Oncologia Medica L.e A. Seragnoli Bologna, Italy Azienda Sanitaria di Bolzano - Ospedale Centrale - Ematologia e Centro TMO Bolzano, Italy Azienda ASL di Cagliari Cagliari, Italy, 9121 U.O.C. di Onco-Ematologia - Centro di Ricerca e Formazione ad Alta tecnologia nelle Scienze Biomediche Campobasso, Italy Ospedale Ferrarotto Catania, Italy, 95124 Azienda Ospedaliera Pugliese Ciaccio Catanzaro, Italy, 88100 U.O. Ematologia - P.O. Annunziata - A.O. di Cosenza Cosenza, Italy Sez.Ematologia e Dip. scienze Biomediche Arcispedale S. Anna Ferrara, Italy, 44100 Policlinico di Careggi, Università delgi studi di Firenze Firenze, Italy Clinica Ematologica - Università degli Studi Genova, Italy ASL Le1 P.O. Vito Fazzi - U.O. di Ematologia Lecce, Italy, 73100 Azienda Ospedaliera Universitaria - Policlinico G. Martino Dipartimento di Medicina Interna - U.O. Messina Messina, Italy Messina Divisione di Ematologia - Azienda Ospedaliera Ospedali Riuniti "Papardo Piemonte" Messina, Italy Centro Trapianti di Midollo - IRCCS Ospedale Maggiore Policlinico Milano, Italy Unità Trapianto di Midollo Ist. Nazionale Tumori Milano, Italy Sez. di medicina Interna Oncologia ed Ematologia Modena, Italy Ospedale San Gennaro - ASL Napoli 1 Napoli, Italy, 80143 U.O. Ematologia Clinica - Azienda USL di Pescara Pescara, Italy Dipartimento Emato-Oncologia A.O. "Bianchi-Melacrino-Morelli" Reggio Calabria, Italy S.C. di Ematologia e Trapianti - I.F.O. Istituto Nazionale Tumori Regina Elena Roma, Italy Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia Roma, Italy Università degli Studi - Policlinico di Tor Vergata Roma, Italy Università degli studi di Roma La Cattolica Roma, Italy Ospedale S.Eugenio Rome, Italy, 00144 Ospedale Casa Sollievo della sofferenza San Giovanni Rotondo, Italy U.O. Ematologia, Azienda Ospedaliera Universitaria Senese Siena, Italy, 53100 SS.C. di Oncoematologia - Dipartimento di Medicina Clinica e Sperimentale - Azienda Ospedaliera - S. Maria Di Terni Terni, Italy Div. di Ematologia "Molinette" Osp. Maggiore S. G. Battista Torino, Italy Clinica Ematologica - Policlinico Universitario Udine, Italy Policlinico G.B. Rossi Verona, Italy, 37134 Less <<
NCT02162888 Cancer Which Has Either Progre... More >>ssed or Relapsed After Standard Therapy, or for Which no Curative or Standard Therapy is Appropriate Less << Phase 1 Completed - United States, California ... More >> Oncology Institute of Hope and Innovation Long Beach, California, United States United States, Kansas Cancer Center of Kansas Wichita, Kansas, United States United States, New Jersey Regional Cancer Care Associates Cherry Hill, New Jersey, United States United States, Pennsylvania Penn State University Hershey Medical Center Hershey, Pennsylvania, United States United States, South Carolina Greenville Hospital System University Medical Center Greenville, South Carolina, United States United States, Texas Texas Oncology Fort Worth, Texas, United States Scott & White Healthcare Temple, Texas, United States United States, Virginia Virginia Oncology Associates Norfolk, Virginia, United States United States, Washington Evergreen Hematology & Oncology Spokane, Washington, United States Yakima Valley Memorial Hospital/North Star Lodge Yakima, Washington, United States Less <<
NCT02434484 - Recruiting June 2020 Korea, Republic of ... More >> Eisai Trial Site #7 Not yet recruiting Busan, Korea, Republic of Eisai Trial Site #8 Not yet recruiting Busan, Korea, Republic of Eisai Trial Site #6 Not yet recruiting Daegu, Korea, Republic of Eisai Trial Site #4 Recruiting Daejeon, Korea, Republic of Eisai Trial Site #5 Not yet recruiting Daejeon, Korea, Republic of Eisai Trial Site #9 Not yet recruiting Incheon, Korea, Republic of Eisai Trial Site #1 Not yet recruiting Seoul, Korea, Republic of Eisai Trial Site #2 Not yet recruiting Seoul, Korea, Republic of Eisai Trial Site #3 Not yet recruiting Seoul, Korea, Republic of Less <<
NCT01974440 Lymphoma Phase 3 Active, not recruiting August 3, 2021 -
NCT02717624 Mantle Cell Lymphoma (MCL) Phase 1 Active, not recruiting May 2026 United States, Kentucky ... More >> Louisville, Kentucky, United States United States, Michigan Ann Arbor, Michigan, United States United States, New Jersey Hackensack, New Jersey, United States Morristown, New Jersey, United States United States, New York Lake Success, New York, United States United States, Ohio Columbus, Ohio, United States United States, Tennessee Nashville, Tennessee, United States United States, Texas Houston, Texas, United States United States, Washington Seattle, Washington, United States Italy Bologna, Italy Poland Krakow, Poland Olsztyn, Poland Warsaw, Poland Łódź, Poland Less <<
NCT01465230 Chronic Lymphocytic Leukemia Phase 2 Terminated(This study was unsu... More >>ccessful in enrolling the target number of subjects during the funding period.) Less << - United States, Connecticut ... More >> Yale Cancer Center New Haven, Connecticut, United States, 06519 Less <<
NCT02836639 Lymphoma, Non-Hodgkin Phase 2 Recruiting - Korea, Republic of ... More >> Pusan National University Hospital Recruiting Busan, Korea, Republic of Contact: Hojin Shin       hojinja@hanmail.net Less <<
NCT01056510 Lymphocytic Leukemia, Chronic Phase 4 Completed - -
NCT01056510 - Completed - -
NCT01133158 - Completed - -
NCT02954406 Lymphoma, Non-Hodgkin Phase 1 Recruiting April 26, 2019 United States, Arizona ... More >> University of Arizona Cancer Center, Tucson Recruiting Tucson, Arizona, United States, 85724 United States, California University of California San Diego (UCSD) - Moores Cancer Center Recruiting La Jolla, California, United States, 92093 Cedars-Sinai Medical Center (CSMC) - Samuel Oschin Comprehensive Cancer Institute Not yet recruiting West Hollywood, California, United States, 90048 United States, Kentucky University of Louisville Kentucky James Graham Brown Cancer Center Recruiting Louisville, Kentucky, United States, 40202 United States, Maryland Center for Cancer and Blood Disorders Recruiting Bethesda, Maryland, United States, 20817 United States, Massachusetts Tufts Medical Center Not yet recruiting Boston, Massachusetts, United States, 02111 United States, Michigan Henry Ford Hospital Recruiting Detroit, Michigan, United States, 48202-2608 United States, New York NYU Langone Medical Center - NYU Medical Oncology Associates Recruiting New York, New York, United States, 10016-4744 United States, North Carolina University of North Carolina - Lineberger Comprehensive Cancer Center Recruiting Chapel Hill, North Carolina, United States, 27514 United States, Ohio University Hospitals of Cleveland Recruiting Cleveland, Ohio, United States, 44106 United States, West Virginia West Virginia University Recruiting Morgantown, West Virginia, United States, 26506 Canada, Nova Scotia Queen Elizabeth II Health Sciences Centre Recruiting Halifax, Nova Scotia, Canada, B3H 2Y9 Canada, Quebec McGill University - Jewish General Hospital Recruiting Montreal, Quebec, Canada, H3T 1E2 Less <<
NCT01133158 Non-Hodgkin's Lymphoma Phase 2 Completed - Spain ... More >> Complejo Hospitalario Universitario de Santiago Santiago, A Coruña, Spain, 15706 Hospital Txagorritxu Vitoria, Alava, Spain, 01009 Hospital San Juan de Alicante San Juan de Alicante, Alicante, Spain, 03550 Hospital Germans Trias i Pujol Badalona, Barcelona, Spain, 08916 Hospital de Galdakao Galdakao, Bilbao, Spain, 48960 Hospital Marqués de Valdecilla Santander, Cantabria, Spain, 39008 Hospital de Jerez Jerez de la Frontera, Cádiz, Spain, 11407 Hospital Fundación de Alcorcón Alcorcón, Madrid, Spain, 289222 Hospital de Getafe Getafe, Madrid, Spain, 28901 Hospital Severo Ochoa Leganés, Madrid, Spain, 28911 Hospital Puerta de Hierro Majadahonda, Madrid, Spain, 28222 Hospital Son Llàtzer Palma de Mallorca, Mallorca, Spain, 07010 Hospital Son Espases Palma de Mallorca, Mallorca, Spain, 07014 Hospital Universitario Virgen de Arrixaca El Palmar, Murcia, Spain, 30120 Clínica Universitaria de Navarra Pamplona, Navarra, Spain, 31008 Hospital Universitario de Canarias La Laguna, Tenerife, Spain, 38320 Complejo Hospitalario Universitario A Coruña A Coruña, Spain, 15006 Hospital del Mar Barcelona, Spain, 08003 Hospital Vall d´Hebron Barcelona, Spain, 08035 Hospital Clinic i Provincial Barcelona, Spain, 08036 Hospital de Basurto Bilbao, Spain, 48013 Hospital San Pedro Alcántara Cáceres, Spain, 10002 Hospital Puerta del Mar Cádiz, Spain, 11009 Hospital de Jaén Jaén, Spain, 23007 Hospital Gregorio Marañón Madrid, Spain, 28009 Hospital Ramón y Cajal Madrid, Spain, 28034 Hospital 12 de Octubre Madrid, Spain, 28041 Hospital La Paz Madrid, Spain, 28046 Hospital Morales Meseguer Murcia, Spain, 30008 Complejo Hospitalario Carlos Haya Málaga, Spain, 29010 Hospital de Salamanca Salamanca, Spain, 37007 Hospital General de Segovia Segovia, Spain, 42002 Hospital Virgen del Rocío Sevilla, Spain, 41013 Hospital Clínico Universitario de Valencia Valencia, Spain, 46010 Hospital General de Valencia Valencia, Spain, 46014 Hospital Arnau de Vilanova Valencia, Spain, 46015 Hospital Universitario Dr. Peset Valencia, Spain, 46017 Hospital Río Hortega Valladolid, Spain, 47012 Hospital Virgen de la Concha Zamora, Spain, 49022 Hospital Clínico de Zaragoza Zaragoza, Spain, 50009 Hospital Miguel Servet Zaragoza, Spain, 50009 Less <<
NCT00856830 Small Cell Lung Cancer ... More >> Extensive Stage Lung Cancer Chemonaive Less << Phase 1 Phase 2 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 - 0104 United States, Georgia Georgia Cancer Specialists Marietta, Georgia, United States, 30060 Less <<
NCT01671904 Chronic Lymphocytic Leukemia Phase 1 Active, not recruiting June 25, 2020 United States, California ... More >> University of California San Diego Medical Center La Jolla, California, United States, 92093-5354 United States, Illinois Ingalls Hospital; Cancer Clinical Trials Harvey, Illinois, United States, 60426 United States, Michigan Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Washington Evergreen Hematology and Oncology Spokane, Washington, United States, 99218 North Star Lodge Yakima, Washington, United States, 98902 Yakima Valley Memorial Hospital/North Star Lodge Yakima, Washington, United States, 98902 France Hopital Claude Huriez Lille, France, 59037 Hopital Saint Eloi Montpellier, France, 34295 Centre Hospitalier Lyon Sud Pierre Benite, France, 69495 Centre Henri Becquerel Rouen, France, 76038 Germany Apotheke des Universitätsklinikums Freiburg Freiburg, Germany, 79106 UKSH Klinik für Innere Medizin II, Hämatologie und Internistische Onkologie Kiel, Germany, 24105 Universitatsklinik Koln Köln, Germany, 50924 Klinikum Schwabing München, Germany, 80804 Universtitätsklinikum Ulm; Klinik für Innere Medizin III Ulm, Germany, 89081 Less <<
NCT00856830 - Completed - -
NCT00612183 Non-Hodgkin's Lymphoma ... More >> Mantle Cell Lymphoma Less << Phase 2 Completed - Japan ... More >> Nagoya, Aichi, Japan Kashiwa, Chiba, Japan Sapporo, Hokkaido, Japan Isehara, Kanagawa, Japan Sendai, Miyagi, Japan Moriguchi, Osaka, Japan Hamamatsu, Shizuoka, Japan Utsunomiya, Tochigi, Japan Chuo, Tokyo, Japan Koto, Tokyo, Japan Shibuya, Tokyo, Japan Shinagawa, Tokyo, Japan Fukuoka, Japan Kagoshima, Japan Kumamoto, Japan Kyoto, Japan Nagoya, Japan Less <<
NCT02257567 Lymphoma Phase 1 Phase 2 Recruiting July 12, 2021 -
NCT01523860 Follicular Lymphoma Phase 2 Completed - Italy ... More >> Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.) Meldola, Forlì-Cesena, Italy, 47014 Ematologia e Trapianto Ospedale Card.Panico Tricase, Lecce, Italy Ematologia, A.O. San Gerardo Monza, Milano, Italy, 20052 Oncologia Medica ed Ematologia, Istituto Clinica Humanitas Rozzano, Milano, Italy, 20089 Divisione di Oncologia Medica A, Centro di Riferimento Oncologico Aviano, Pordenone, Italy, 33081 UO Oncologia ed Onco-Ematologia, Ospedale di Rimini Rimini, Rn, Italy Divisione di Ematologia Ospedale SS. Antonio e Biagio Alessandria, Italy, 15100 SOS Ematologia Ospedale C. Massaia Asti, Italy, 14100 Ematologia con Trapianto, Università di Bari Bari, Italy, 70124 Medicina Interna, Ospedale degli Infermi Biella, Italy, 13800 Istituto di Ematologia ed Oncologia Medica A. Seragnoli Policlinico S. Orsola Bologna, Italy, 40138 Divisione di Ematologia e TMO, Ospedale di Bolzano Bolzano, Italy, 39100 S.C. di Ematologia, Spedali Civili Brescia, Italy, 25123 Divisione di Ematologia, Ospedale Businco Cagliari, Italy, 09121 Divisione di Ematologia, Ospedale di Catania Catania, Italy Azienda Ospedaliera Santa Croce e Carle Cuneo, Italy, 12100 Clinica Ematologica Policlinico Carreggi Firenze, Italy, 50134 Divisione di Ematologia, Policlinico Careggi Firenze, Italy Ematologia I, A.O.U. San Martino Genova, Italy, 16132 S.C. Medicina Trasfusionale ed Ematologia , P.O. Ivrea Ivrea, Italy, 10015 S.C. Ematologia, Azienda Ospedaliera Papardo Messina, Italy, 98158 Divisione di Ematologia, Ospedale Niguarda Milano, Italy, 20162 Ematologia e Trapianto IRCCS, Istituto Nazionale dei Tumori Milano, Italy Policlinico La Marcora Milano, Italy UO Ematologia, II Facoltà di Medicina e Chirurgia Università Federico II Napoli, Italy, 80131 SCDU Ematologia, AOU Maggiore della Carità Novara, Italy, 28100 UO Ematologia, Università - Policlinico San Matteo Pavia, Italy, 27100 Ematologia Ospedale Santa Maria delle Croci Ravenna, Italy, 48100 Div. Ematologia A.O. "Bianchi Melacrino Morelli" Reggio Calabria, Italy, 89100 Università Cattolica del Sacro Cuore Roma, Italy, 00168 Dipartimento di biotecnologie cellulari ed ematologia Ospedale Umberto I, Università La Sapienza Roma, Italy Ospedale Santa Maria di Terni Terni, Italy, 05100 Osp. San Giovanni Battista - Biologia Molecolare Torino, Italy, 10126 Osp. San Giovanni Battista - Ematologia 2 Torino, Italy, 10126 Ospedale S. Chiara Trento, Italy Ematologia Ospedale Santa Maria Di Ca' Foncello Treviso, Italy, 31100 Clinica di Ematologia, A.O.U. di Udine Udine, Italy, 33100 Less <<
NCT01423539 Diffuse Large B-Cell Lymphoma Phase 2 Withdrawn(The NAVIGATE study h... More >>as been terminated due to non-safety related reasons.) Less << February 2014 United States, California ... More >> Fountain Valley, California, United States, 92708 United States, Florida Hudson, Florida, United States, 34667 United States, Georgia Lawrenceville, Georgia, United States, 30045 United States, Illinois Centralia, Illinois, United States, 62801 Harvey, Illinois, United States, 60426 United States, Indiana Terre Haute, Indiana, United States, 47802 United States, Kentucky Hazard, Kentucky, United States, 41701 Paducah, Kentucky, United States, 42003 United States, Maryland Rockville, Maryland, United States, 20850 United States, Missouri Jefferson City, Missouri, United States, 65109 United States, Montana Great Falls, Montana, United States, 59405 United States, Ohio Newark, Ohio, United States, 43055 United States, Tennessee Nashville, Tennessee, United States, 37203 Less <<
NCT01466153 Chronic Lymphocytic Leukemia (... More >>CLL) Less << Phase 2 Completed - -
NCT01776840 Mantle Cell Lymphoma Phase 3 Active, not recruiting October 12, 2021 -
NCT01832597 - Completed - Italy ... More >> UO di Ematologia, S.O. Annunziata Cosenza, CZ, Italy, 87100 Dipartimento di Oncologia, Ematologia e Patologie dell'Apparato Respiratorio, Universita` di Modena e Reggio Emilia Modena, MO, Italy, 41124 UO di Ematologia, AOUP Paolo Giaccone, Palermo, PA, Italy, 90127 Less <<
NCT02148913 Multiple Myeloma Phase 1 Active, not recruiting December 2018 United States, Michigan ... More >> Spectrum Health Grand Rapids, Michigan, United States, 49503 Less <<
NCT01332617 Myeloma Phase 2 Withdrawn(Investigators no lon... More >>ger interested in activating study) Less << February 2019 -
NCT01466153 - Completed - -
NCT01612988 B-cell Chronic Lymphocytic Leu... More >>kemia (B-CLL) Less << Phase 2 Terminated(Other drugs others ... More >>studies) Less << - France ... More >> Tournilhac Clermont Ferrand, France, 63000 Less <<
NCT00168922 Recurrent Small Cell Lung Canc... More >>er Less << Phase 2 Unknown - Germany ... More >> Hematology & Oncology Charité CBF Berlin, Germany Recruiting Berlin, Germany, 12203 Contact: Ulrich Keilholz, MD    +49-30-8445-3596    ulrich.keilholz@charite.de    Contact: Alexander Schmittel, MD    +49-30-8445-3090    alexander.schmittel@charite.de Less <<
NCT00069758 Non-Hodgkin's Lymphoma PHASE2 COMPLETED 2025-04-07 University of Alabama at Birmi... More >>ngham, Birmingham, Alabama, 35294-3300, United States|Comprehensive Cancer Center-Desert Regional Medical Center, Palm Springs, California, 92262, United States|San Diego Cancer Center, Vista, California, 92083, United States|Georgetown University Medical Center - Lombardi Cancer Center, Washington, District of Columbia, 20007, United States|Mountain States Tumor Institute, Boise, Idaho, 83712, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02115, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, 48109, United States|The Cancer Institute of New Jersey, New Brunswick, New Jersey, 08901, United States|University of Rochester Medical Center, Rochester, New York, 14642, United States|The Sarah Cannon Cancer Center, Nashville, Tennessee, 37203, United States|Southwest Regional Cancer Center, Austin, Texas, 78705, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States|University of Virginia Medical Center, Charlottesville, Virginia, 22908, United States|Queen Elizabeth Health Sciences Centre, Halifax, Nova Scotia, B3H 2Y9, Canada|The Ottawa Hospital - General Campus, Ottawa, Ontario, K1H 8L6, Canada|Toronto Sunnybrook Regional Cancer Centre, Toronto, Ontario, M4N 3M5, Canada|CHA Hopital Enfant-Jesus, Quebec, G1J 1Z4, Canada Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.53mL

0.51mL

0.25mL

12.67mL

2.53mL

1.27mL

25.33mL

5.07mL

2.53mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

Reference

[1]Leoni LM, Bailey B, et al. Bendamustine (Treanda) displays a distinct pattern of cytotoxicity and unique mechanistic features compared with other alkylating agents. Clin Cancer Res. 2008 Jan 1;14(1):309-17.

[2]Schwanen C, Hecker T, et al. In vitro evaluation of bendamustine induced apoptosis in B-chronic lymphocytic leukemia. Leukemia. 2002 Oct;16(10):2096-105.

[3]Leoni LM, Bailey B, Reifert J, Bendall HH, Zeller RW, Corbeil J, Elliott G, Niemeyer CC. Bendamustine (Treanda) displays a distinct pattern of cytotoxicity and unique mechanistic features compared with other alkylating agents. Clin Cancer Res. 2008 Jan 1;14(1):309-17

[4]Cives M, Ciavarella S, Rizzo FM, De Matteo M, Dammacco F, Silvestris F. Bendamustine overcomes resistance to melphalan in myeloma cell lines by inducing cell death through mitotic catastrophe. Cell Signal. 2013 May;25(5):1108-17

[5]LaCasce AS, Bociek RG, Sawas A, Caimi P, Agura E, Matous J, Ansell SM, Crosswell HE, Islas-Ohlmayer M, Behler C, Cheung E, Forero-Torres A, Vose J, O'Connor OA, Josephson N, Wang Y, Advani R. Brentuximab vedotin plus bendamustine: a highly active first salvage regimen for relapsed or refractory Hodgkin lymphoma. Blood. 2018 Jul 5;132(1):40-48

[6]Bogeljić Patekar M, Milunović V, Mišura Jakobac K, Perica D, Mandac Rogulj I, Kursar M, Planinc-Peraica A, Ostojić Kolonić S. BENDAMUSTINE: AN OLD DRUG IN THE NEW ERA FOR PATIENTS WITH NON-HODGKIN LYMPHOMAS AND CHRONIC LYMPHOCYTIC LEUKEMIA. Acta Clin Croat. 2018 Sep;57(3):542-553

 

Categories